
<html lang="en"     class="pb-page"  data-request-id="84adc323-e73e-4fd1-bb31-97d8497f80e9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-17;pageGroup:string:Publication Pages;article:article:10.1021/jm100697g;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1 Receptor Agonist with Unprecedented Selectivity and Procognitive Potential" /></meta><meta name="dc.Creator" content="Anette G.  Sams" /></meta><meta name="dc.Creator" content="Morten  Hentzer" /></meta><meta name="dc.Creator" content="Gitte K.  Mikkelsen" /></meta><meta name="dc.Creator" content="Krestian  Larsen" /></meta><meta name="dc.Creator" content="Christoffer  Bundgaard" /></meta><meta name="dc.Creator" content="Niels  Plath" /></meta><meta name="dc.Creator" content="Claus T.  Christoffersen" /></meta><meta name="dc.Creator" content="Benny  Bang-Andersen" /></meta><meta name="dc.Description" content="The discovery and structure−activity relationship (SAR) of a series of allosteric muscarinic M1 receptor agonists are described. Compound 17 (Lu AE51090) was identified as a representative compound..." /></meta><meta name="Description" content="The discovery and structure−activity relationship (SAR) of a series of allosteric muscarinic M1 receptor agonists are described. Compound 17 (Lu AE51090) was identified as a representative compound..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 4, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100697g" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100697g" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100697g" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100697g" /></link>
        
    
    

<title>Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1 Receptor Agonist with Unprecedented Selectivity and Procognitive Potential | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100697g" /></meta><meta property="og:title" content="Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1 Receptor Agonist with Unprecedented Selectivity and Procognitive Potential" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0011.jpeg" /></meta><meta property="og:description" content="The discovery and structure−activity relationship (SAR) of a series of allosteric muscarinic M1 receptor agonists are described. Compound 17 (Lu AE51090) was identified as a representative compound from the series, based on its high selectivity as an agonist at the muscarinic M1 receptor across a panel of muscarinic receptor subtypes. Furthermore, 17 displayed a high degree of selectivity when tested in a broad panel of G-protein-coupled receptors, ion channels, transporters, and enzymes, and 17 showed an acceptable pharmacokinetic profile and sufficient brain exposure in rodents in order to characterize the compound in vivo. Hence, in a rodent model of learning and memory, 17 reversed delay-induced natural forgetting, suggesting a procognitive potential of 17." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100697g"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100697g">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100697g&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100697g&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100697g&amp;href=/doi/10.1021/jm100697g" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6386-6397</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100545a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100567y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M<sub>1</sub> Receptor Agonist with Unprecedented Selectivity and Procognitive Potential</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anette+G.++Sams">Anette G. Sams</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Morten++Hentzer">Morten Hentzer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gitte+K.++Mikkelsen">Gitte K. Mikkelsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Krestian++Larsen">Krestian Larsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoffer++Bundgaard">Christoffer Bundgaard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niels++Plath">Niels Plath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus+T.++Christoffersen">Claus T. Christoffersen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benny++Bang-Andersen">Benny Bang-Andersen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Medicinal Chemistry Research</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Molecular Pharmacology</span></div><div class="aff-info" id="affc"><span class="aff-symbol">§</span> <span class="aff-text">Discovery ADME</span></div><div class="aff-info" id="affd"><span class="aff-symbol">∥</span> <span class="aff-text">In Vivo Neuropharmacology</span></div><div class="aff-info" id="hlrd"><span class="aff-text">Lundbeck Research Denmark, H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby, Denmark</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Current address: LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark. Phone: +45 44945888. Fax: +45 72263320. E-mail: <a href="/cdn-cgi/l/email-protection#afcec1cadbdbca81dccec2dcefc3cac082dfc7ceddc2ce81ccc0c2"><span class="__cf_email__" data-cfemail="fa9b949f8e8e9fd4899b9789ba969f95d78a929b88979bd4999597">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100697g&amp;href=/doi/10.1021%2Fjm100697g" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6386–6397</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 4, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 June 2010</li><li><span class="item_label"><b>Published</b> online</span>4 August 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 September 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100697g" title="DOI URL">https://doi.org/10.1021/jm100697g</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6386%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnette%2BG.%2BSams%252C%2BMorten%2BHentzer%252C%2BGitte%2BK.%2BMikkelsen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D17%26contentID%3Djm100697g%26title%3DDiscovery%2Bof%2BN-%257B1-%255B3-%25283-Oxo-2%252C3-dihydrobenzo%255B1%252C4%255Doxazin-4-yl%2529propyl%255Dpiperidin-4-yl%257D-2-phenylacetamide%2B%2528Lu%2BAE51090%2529%253A%2BAn%2BAllosteric%2BMuscarinic%2BM1%2BReceptor%2BAgonist%2Bwith%2BUnprecedented%2BSelectivity%2Band%2BProcognitive%2BPotential%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6397%26publicationDate%3DSeptember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100697g"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2024</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100697g" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1 Receptor Agonist with Unprecedented Selectivity and Procognitive Potential&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anette&quot;,&quot;last_name&quot;:&quot;G. Sams&quot;},{&quot;first_name&quot;:&quot;Morten&quot;,&quot;last_name&quot;:&quot;Hentzer&quot;},{&quot;first_name&quot;:&quot;Gitte&quot;,&quot;last_name&quot;:&quot;K. Mikkelsen&quot;},{&quot;first_name&quot;:&quot;Krestian&quot;,&quot;last_name&quot;:&quot;Larsen&quot;},{&quot;first_name&quot;:&quot;Christoffer&quot;,&quot;last_name&quot;:&quot;Bundgaard&quot;},{&quot;first_name&quot;:&quot;Niels&quot;,&quot;last_name&quot;:&quot;Plath&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;T. Christoffersen&quot;},{&quot;first_name&quot;:&quot;Benny&quot;,&quot;last_name&quot;:&quot;Bang-Andersen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6386-6397&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100697g&quot;},&quot;abstract&quot;:&quot;The discovery and structure−activity relationship (SAR) of a series of allosteric muscarinic M1 receptor agonists are described. Compound 17 (Lu AE51090) was identified as a representative compound from the series, based on its high selectivity as an agonist at the muscarinic M1 receptor across a panel of muscarinic receptor subtypes. Furthermore, 17 displayed a high degree of selectivity when tested in a broad panel of G-protein-coupled receptors, ion channels, transporters, and enzymes, and 17 showed an acceptable pharmacokinetic profile and sufficient brain exposure in rodents in order to characterize the compound in vivo. Hence, in a rodent model of learning and memory, 17 reversed delay-induced natural forgetting, suggesting a procognitive potential of 17.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100697g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100697g" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100697g&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100697g" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100697g&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100697g" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100697g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100697g&amp;href=/doi/10.1021/jm100697g" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100697g" /></input><a href="/doi/pdf/10.1021/jm100697g" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100697g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100697g%26sid%3Dliteratum%253Aachs%26pmid%3D20684563%26genre%3Darticle%26aulast%3DSams%26date%3D2010%26atitle%3DDiscovery%2Bof%2BN-%257B1-%255B3-%25283-Oxo-2%252C3-dihydrobenzo%255B1%252C4%255Doxazin-4-yl%2529propyl%255Dpiperidin-4-yl%257D-2-phenylacetamide%2B%2528Lu%2BAE51090%2529%253A%2BAn%2BAllosteric%2BMuscarinic%2BM1%2BReceptor%2BAgonist%2Bwith%2BUnprecedented%2BSelectivity%2Band%2BProcognitive%2BPotential%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D17%26spage%3D6386%26epage%3D6397%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jmcmar.2010.53.issue-17/production/jmcmar.2010.53.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery and structure−activity relationship (SAR) of a series of allosteric muscarinic M<sub>1</sub> receptor agonists are described. Compound <b>17</b> (Lu AE51090) was identified as a representative compound from the series, based on its high selectivity as an agonist at the muscarinic M<sub>1</sub> receptor across a panel of muscarinic receptor subtypes. Furthermore, <b>17</b> displayed a high degree of selectivity when tested in a broad panel of G-protein-coupled receptors, ion channels, transporters, and enzymes, and <b>17</b> showed an acceptable pharmacokinetic profile and sufficient brain exposure in rodents in order to characterize the compound in vivo. Hence, in a rodent model of learning and memory, <b>17</b> reversed delay-induced natural forgetting, suggesting a procognitive potential of <b>17</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Muscarinic (M) acetylcholine (ACh<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: SAR, structure−activity relationship; AD, Alzheimer's disease; CNS, central nervous system; ADME, absorption, distribution, metabolism, excretion; AUC, area under the curve; iv, intravenous; ITI, intertrial interval; CHO, Chinese hamster ovary; BHK, baby hamster kidney; PI, phosphoinisitol; GPCR, G-protein-coupled receptor; ACh, acetylcholine; CCh, carbachol; SPA, scintillation proximity assay; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; EDTA, ethylenediaminetetraacetic acid; SCX, strong cation exchange; DMF, dimethylformamide; THF, tetrahydrofuran; DIPEA, diisopropylethylamine; TFA, trifluoroacetic acid; CDI, carbonyl diimidazole; MTBD, 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene; LC/MS−MS, liquid chromatography−tandem mass spectrometry; ELSD, evaporative light scattering detection.</p></div> receptors are members of superfamily A of the G-protein-coupled receptors (GPCRs) and mediate the action of the neurotransmitter ACh in the peripheral and central nervous system (CNS). Five muscarinic receptor subtypes (M<sub>1</sub>−M<sub>5</sub>) have been cloned. The M<sub>1</sub>, M<sub>3</sub>, and M<sub>5</sub> receptors couple to G<sub>q/11</sub>, and their stimulation leads to activation of phospholipase C and increase in phosphoinositol (PI) turnover, resulting in intracellular calcium release. The M<sub>2</sub> and M<sub>4</sub> receptors mediate their signaling via G<sub>i/o</sub>, and activation of these subtypes leads to reduced cAMP production through inhibition of adenylate cyclase activity.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">The M<sub>1</sub> receptor is the predominant muscarinic receptor subtype in the CNS and is located in brain areas such as cerebral cortex and hippocampus. These brain areas are important for learning and memory, and activation of M<sub>1</sub> receptors has been suggested to mediate higher cognitive processing. Moreover, these brain regions are severely affected by cholinergic dysfunction in Alzheimer's disease (AD), from early stages and onward.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> A central role for the M<sub>1</sub> receptor in cognition was first demonstrated in mouse M<sub>1</sub> receptor knockout studies, where M<sub>1</sub> −/− mice revealed deficits in hippocampus and prefrontal cortex dependent working and episodic memory tasks.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> In addition, M<sub>1</sub> receptor expression is decreased in cortical regions of schizophrenia patients, although this has not yet been linked to a functional outcome.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Hence, it has been suggested that M<sub>1</sub> receptor agonism has a role in the treatment of AD and cognitive impairment associated with schizophrenia (CIAS).<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a></div><div class="NLM_p">During the 1990s, several pharmaceutical companies pursued selective muscarininc M<sub>1</sub> receptor agonists as potential therapeutics for the treatment of AD and schizophrenia. While many of the compounds were efficacious in preclinical animal models of cognitive dysfunction, those compounds that were progressed into clinical studies were dose limited by various adverse effects, including vomiting, nausea, and sweating, which prohibited their use in clinical practice of AD treatment.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, in clinical studies <b>1</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) demonstrated an effect on cognitive and behavioral symptoms in AD patients<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and on measures of verbal learning and short-term memory functions in schizophrenic patients.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Many of the first generation M<sub>1</sub> receptor agonists were invented on the basis of structures of naturally occurring, nonselective muscarinic receptor agonists, such as arecholine.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The moderate selectivity of these compounds for M<sub>1</sub> receptors over the other muscarinic receptor subtypes, especially M<sub>2</sub> and M<sub>3</sub> receptors,<a onclick="showRef(event, 'ref8 ref12 ref18'); return false;" href="javascript:void(0);" class="ref ref8 ref12 ref18">(8, 12, 18)</a> has been suggested to be the cause of the observed peripheral cholinergic side effects.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Muscarinic Agonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The modest selectivity of the first generation M<sub>1</sub> receptor agonists has been suggested to be a direct consequence of these compounds activating the M<sub>1</sub> receptor through orthosteric regions, which display a high level of sequence homology among the subtypes of the muscarinic receptor family. Spalding et al. reported the discovery of an allosteric muscarinic M<sub>1</sub> receptor agonist <b>2</b> (AC-42)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> belonging to a novel structural class of muscarinic receptor agonists. It was shown that <b>2</b> displayed complete selectivity as an agonist of the M<sub>1</sub> receptor versus the other muscarinic receptor subtypes. Mutagenesis and pharmacological studies later revealed that this compound activates the muscarinic M<sub>1</sub> receptor with a mode of action different from that of orthosteric muscarinic receptor agonists.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><div class="NLM_p">The discovery of allosteric M<sub>1</sub> receptor agonists spurred a renewed interest in the muscarinic field, and a number of allosteric agonists of the M<sub>1</sub> receptor have since appeared. These second generation muscarinic M<sub>1</sub> receptor agonists have a potential for subtype selectivety, since they activate the receptor through interaction with less conserved regions among the muscarinic receptor subtypes. Subsequent to the discovery of <b>2</b>, other compounds have been reported as allosteric agonists of the muscarinic M<sub>1</sub> receptor, such as <b>3</b> (NDMC),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> a metabolite of the atypical antipsychotic drug clozapine, and more recently <b>4</b> (TBPB)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was reported.</div><div class="NLM_p last">A small screening campaign was conducted in our laboratory to identify allosteric muscarinic M<sub>1</sub> receptor agonists using a functional Ca<sup>2+</sup> flux assay. Here, we report the discovery of <b>5</b> and a related analogue <b>6</b> and their development into a novel series of allosteric M<sub>1</sub> receptor agonists. From this series, the allosteric M<sub>1</sub> receptor partial agonist <b>17</b> (Lu AE51090) was selected and further characterized. In short, <b>17</b> displayed unprecedented selectivity for the muscarinic M<sub>1</sub> receptor versus other muscarinic receptor subtypes, when assayed for functional agonism and in binding assays. Compound <b>17</b> also displayed high selectivity when tested in a panel of 69 receptors, ion channels, transporters, and enzymes. Also, <b>17</b> had suitable pharmacokinetic properties and was active in an in vivo model of working memory, making it a high quality lead compound for a drug discovery program.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A parallel synthesis protocol was developed in order to explore the SAR of the two initial hits <b>5</b> and <b>6</b> in a rapid manner, as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Commercially available <i>tert</i>-butyl 4-aminopiperidine-1-carboxylate was acylated with an excess of a suitable carboxylic acid chloride in the presence of TBD-methylpolystyrene, a polymer immobilized version of the organic base 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), to drive the acylation reaction to completion. The residual carboxylic acid chloride was removed by the addition of tris-(2-aminoethyl)amine polystyrene as a scavenger. The resins were subsequently removed by filtration, and the resulting crude product was deprotected by addition of trifluoroacetic acid to the solution. The solvent was evaporated and the residue redissolved in MeOH and loaded onto a sulfonic acid based strong-cation-exchange (SCX) column. The loaded SCX column was washed repeatedly with MeOH and acetonitrile to remove nonbasic impurities, and the adsorbed piperidin-4-ylcarboxamide was subsequently eluted by rinsing the column with 4 M NH<sub>3</sub> in MeOH. The fractions containing the product were evaporated and redissolved in DMF and finally alkylated with the intermediates <b>8a</b>−<b>l</b> in the presence of DIPEA. By this protocol, compounds <b>6</b>, <b>9</b>−<b>16</b>, <b>18</b>−<b>20</b>, <b>22</b>−<b>32</b>, <b>34</b>, and <b>35</b> were obtained. The intermediate <b>8l</b> was commercially available, while intermediates <b>8a</b>−<b>k</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Thus, suitably substituted 4<i>H</i>-benzo[1,4]oxazin-3-ones <b>7a</b>,<b>j</b> or 3,4-dihydro-1<i>H</i>-quinolin-2-ones <b>7b</b>−<b>i</b> and 4<i>H</i>-benzo[1,4]thiazin-3-one <b>7k</b> were deprotonated with NaH and alkylated with 1,3-dibromopropane or 1-bromo-3-chloropropane, as specified in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The intermediates <b>7a</b>,<b>b</b>,<b>d</b>−<b>f</b>,<b>h</b>,<b>i</b>,<b>k</b> were commercially available, while <b>7c</b>, <b>7g</b>, and <b>7j</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. 2-Fluoro-6-nitrobenzyl bromide was reacted with diethyl malonate, followed by diethyl ester hydrolysis and subsequent decarboxylation of one of the carboxy groups to give <b>39</b> in 79% yield. The nitro group of <b>39</b> was reduced to give the corresponding aniline, which was subsequently cyclized to give <b>7c</b> in 96% yield. The intermediate <b>7g</b> was prepared by acylating 3,4-difluoroaniline with 3-chloropropionyl chloride followed by a Friedel−Crafts alkylation to effect ring closure in 37% overall yield. Intermediate <b>7j</b> was obtained by reduction of 4,5-difluoro-2-nitrophenol to the corresponding aniline followed by reaction with chloroacetyl chloride in 70% overall yield. A slight modification of the procedure outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, with simple permutations of the individual steps as described in the <a class="ref internalNav" href="#sec11" aria-label="Experimental Section">Experimental Section</a>, was adopted for the larger scale preparations of compounds <b>5</b>, <b>17</b>, <b>33</b>, and <b>36</b>−<b>38</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Parallel Synthesis Protocol to Prepare Analogues of <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBD-methylpolystyrene, 1,2-dichloroethane; (b) Tris-(2-aminoethyl)amine polystyrene resin; (c) TFA; (d) SCX resin; (e) NH<sub>3</sub>/MeOH (4 M); (f) DIPEA, DMF.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Intermediates <b>8a</b>−<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, Br(CH<sub>2</sub>)<sub>3</sub>X, DMF.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Intermediates <b>7c</b>, <b>7g</b>, and <b>7j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Diethyl malonate, NaH, DMF; (b) AcOH, HCl, reflux; (c) 10% Pd/C, HCOONH<sub>4</sub>, MeOH, reflux; (d) 3-chloropropionyl chloride, DIPEA, ethyl acetate; (e) AlCl<sub>3</sub>, 180 °C; (f) 5% Pd/C, H<sub>2</sub>, EtOH; (g) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Biological Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Biological in vitro assays were employed to determine the pharmacological activity of the compounds and to establish a SAR. Agonist potency (EC<sub>50</sub>) and efficacy (<i>E</i><sub>max</sub>) at the human muscarinic M<sub>1</sub>−M<sub>5</sub> receptors was assayed in functional Ca<sup>2+</sup> mobilization assays using stably transfected Chinese hamster ovary (CHO-K1) cells, expressing the human M<sub>1</sub> or M<sub>2</sub> receptor, or using baby hamster kidney (BHK-21) cells, expressing the human M<sub>3</sub>, M<sub>4</sub>, or M<sub>5</sub> receptor. The cell lines expressing the human M<sub>2</sub> or M<sub>4</sub> receptor coexpressed the promiscuous G<sub>α16</sub> subunit. Agonist evoked increases in intracellular Ca<sup>2+</sup> was measured by fluorometric imaging. Concentration−response data were fitted to the four-parameter logistic equation to estimate compound potency and efficacy of test compounds.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">Binding affinities at human muscarinic M<sub>2</sub>−M<sub>5</sub> receptors were determined by tritium-labeled radioligand binding to membrane preparations from cell lines expressing the respective human muscarinic receptors, using a scintillation proximity assay (SPA) and the radioligands [<sup>3</sup>H]AFDX-384 (M<sub>2</sub>) and [<sup>3</sup>H]4-DAMP (M<sub>3</sub>−M<sub>5</sub>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">In Vitro and in Vivo ADME Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A range of in vitro and in vivo assays were employed to assess the ADME properties of the compounds and to predict the pharmacokinetic properties in humans. The metabolic stability was investigated in cryopreserved hepatocytes of rat and human origin. The first-order elimination rate constant for disappearance of parent compound was calculated from the slope of the logarithm of the transformed concentration−time curve. Plasma protein binding was determined in vitro in rat and human plasma following incubation and ultracentrifugation. In vivo pharmacokinetics were studied in rats following single intravenous (1 mg/kg) and oral (2 mg/kg) administration of compounds. Serial blood samples were collected at various time points up to 6 h after dosing. In vivo pharmacokinetic parameters were obtained following compartmental modeling. The extent of brain penetration was examined in rats and mice following single subcutaneous administration. Animals were anesthetized at different time points, and cardiac blood was obtained followed by decapitation and homogenization of the brain. Bioanalysis of samples from all in vitro and in vivo ADME assays was performed by liquid chromatography−tandem mass spectrometry (LC/MS−MS).</div><div class="NLM_p last">Prediction of hepatic clearance in humans was done by in vitro/in vivo extrapolation from the predicted hepatic clearance in rats and humans according to the well-stirred model<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and the observed systemic in vivo clearance in rats.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A screening campaign covering approximately 10 000 compounds led to the discovery of the potent M<sub>1</sub> receptor agonist <b>5</b> and its close analogue <b>6</b>. The screen was performed using a Ca<sup>2+</sup> mobilization based functional assay with a stably transfected Chinese hamster ovary (CHO-K1) cell line expressing the human M<sub>1</sub> receptor. In this assay, <b>5</b> had an EC<sub>50</sub> of 13 nM and an efficacy (<i>E</i><sub>max</sub>) of 91% relative to the endogenous muscarinic agonist ACh while <b>6</b> was a partial agonist with an EC<sub>50</sub> of 130 nM and an <i>E</i><sub>max</sub> of 86% relative to ACh. The reference compound ACh had an EC<sub>50</sub> of 1.1 nM, and the <i>E</i><sub>max</sub> was defined to 100%.</div><div class="NLM_p">Hit compounds <b>5</b> and <b>6</b> were also tested for agonism at the muscarinic M<sub>2</sub>−M<sub>5</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>5</b> displayed no agonist activity at the M<sub>2</sub> and M<sub>3</sub> receptors, while it was a moderately potent partial agonist at the M<sub>4</sub> receptor (EC<sub>50</sub> = 300 nM, <i>E</i><sub>max</sub> = 48%) as well as a weak partial agonist at the M<sub>5</sub> receptor (EC<sub>50</sub> = 1200 nM, <i>E</i><sub>max</sub> = 52%). In contrast, compound <b>6</b> showed no agonist activity at any of the M<sub>2</sub>−M<sub>5</sub> receptors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Agonism at Muscarinic M<sub>1</sub>−M<sub>5</sub> Receptors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>1</sub></th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>2</sub></th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>3</sub></th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>4</sub></th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>5</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACh</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9% at 10 μM</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10% at 10 μM</td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">38% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7% at 10 μM</td><td class="colsep0 rowsep0" align="left">300</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3% at 10 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6% at 10 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data are the mean of three experiments. Percent activity at the indicated concentration is given when an EC<sub>50</sub> could not be established. nd: not determined.</p></div></div></div><div class="NLM_p">A series of analogues of <b>5</b> and <b>6</b> was prepared, and their potencies and efficacies at the M<sub>1</sub> receptor are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The aim was initially to investigate the contribution of the substituents of the highly decorated scaffold of <b>5</b> to the M<sub>1</sub> receptor activity of the compound. Surprisingly, removal of the two benzylic methoxy substituents led to an equipotent compound <b>9</b>. We subsequently examined the individual effects of fluorine substituents at the aromatic positions of the tetrahydroquinolinone ring system (<b>10</b>−<b>13</b>). The monofluorinated isomers were all less potent than <b>9</b>. In particular, compounds <b>10</b> and <b>13</b> with monofluoro substituents at the 5- or 8-position were approximately 10- to 20-fold weaker when compared to <b>9</b>, while compounds <b>11</b> and <b>12</b> with monofluoro substituents at the 6- or 7-position were only marginally weaker than <b>9</b>. Replacing the fluoro substituents of compounds <b>11</b> and <b>12</b> with methoxy substituents led to a loss of activity, while the fully unsubstituted compound <b>16</b> was equipotent to <b>11</b> and <b>12</b>. The corresponding benzoxazinone derivative <b>17</b> was equipotent to the tetrahydroquinolinone derivative <b>16</b>, while the benzothiazinone derived analogue <b>18</b> was slightly less potent than <b>16</b> and the corresponding benzoxazolone derivative <b>19</b> even less potent. Compound <b>17</b> was subsequently used as the reference for further SAR work around the benzoxazolone scaffold. Thus, methylation of the amide functionality resulted in a substantial loss of M<sub>1</sub> receptor agonism (compound <b>20</b>), and reversing the amide, as in <b>21</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), resulted in an inactive compound. We also explored the effects of changing the amide substituent of <b>17</b>, and replacing the benzyl group of <b>17</b> with a phenyl substituent completely removed M<sub>1</sub> receptor agonist activity, as exemplified with compound <b>22</b>. Also, extending the linker between the carbonyl and phenyl ring as in compound <b>23</b> was unfavorable. However, replacing the benzyl group of <b>17</b> with a methyl group (compound <b>24</b>) only led to a modest 3-fold drop in potency compared to <b>17</b>, and the corresponding ethyl analogue almost restored the M<sub>1</sub> receptor potency to the level of <b>5</b>, yet with significantly less molecular mass (Δ<i>M</i> = 156 Da) (<b>25</b>). Other small alkyl substituents at the amide yielded compounds that were less potent at the M<sub>1</sub> receptor (<b>25</b>−<b>31</b>) compared to <b>25</b>, and R<sup>1</sup> = isobutyl (<b>27</b>) or cyclohexyl (<b>31</b>) gave compounds devoid of M<sub>1</sub> receptor agonism. Interestingly, while all other compounds in the series were partial muscarinic M<sub>1</sub> receptor agonists with relatively high efficacy in the range of 70−90% relative to ACh, compounds <b>29</b> and <b>30</b>, wherein R<sup>1</sup> = cyclobutyl and cyclopentyl, respectively, were partial M<sub>1</sub> receptor agonists with significantly lower <i>E</i><sub>max</sub> of approximately 40% relative to ACh.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inverted amide analogue of <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional M<sub>1</sub> Structure−Activity Relationship for a Series of Analogues of <b>5</b> and <b>6</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0003.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">hM<sub>1</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">Y−Z</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">(3,4-di-OMe)benzyl</td><td class="colsep0 rowsep0" align="left">6,7-di-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">(3-OMe)benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">6,7-di-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">6-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">560</td><td class="colsep0 rowsep0" align="left">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">7-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S-CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">910</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">8% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">(2-phenyl)ethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">970</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">21% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">350</td><td class="colsep0 rowsep0" align="left">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">3% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">6,7-di-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">6,7-di-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">6,7-di-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O−CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">88</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data are the mean of three experiments. When an EC<sub>50</sub> could not be established, activity is given as the percent activity at the concentration indicated. nd: not determined.</p></div></div></div><div class="NLM_p">We repeated the fluoro scan of the aromatic positions of the tetrahydroquinolinone ring system, leading to the ethyl amide derivatives <b>32</b>−<b>35</b>. As was seen for the benzyl substituted amide analogues, a fluorine substituent at the 8-position was unfavorable as exemplified by compounds <b>35</b> and <b>13</b>. However, introducing a fluorine atom at the 5-, 6-, or 7-position yielded largely equipotent compounds, but in this case the 6,7-difluoro substitution pattern did not appear to give a synergistic effect in contrast to what was seen with the benzylic amide substituent (<b>34</b>−<b>36</b> versus <b>9</b>, <b>11</b>, <b>12</b>). Compounds <b>32</b>−<b>34</b>, <b>36</b>, and <b>38</b> were among the most potent compounds of the series, displaying EC<sub>50</sub> values between 10 and 20 nM corresponding to the level of compound <b>5</b>. Also, in this case, the corresponding methyl analogue <b>37</b> was less potent than the ethyl analogue <b>36</b>. In analogy with the benzylamide series, the ethylamide derivative of the 6,7-difluoro substituted benzoxazinone based scaffold (<b>38</b>) was equipotent to the tetrahydroquinolinone-based analogue <b>36</b>.</div><div class="NLM_p">The hit compound <b>5</b> displayed a mixed agonistic profile at the M<sub>1</sub>, M<sub>4</sub>, and M<sub>5</sub> receptors; hence, we monitored the selectivity of selected compounds of the series versus other muscarinic receptor subtypes. It was discovered that the agonistic effects at the M<sub>4</sub> and M<sub>5</sub> receptors observed for <b>5</b> were related to the 3,4-dimethoxy substitution pattern at the benzylic amide substituent, and agonism at M<sub>2</sub>−M<sub>5</sub> was generally not observed in any of the compounds of the series when this substitution pattern was avoided (data not shown).</div><div class="NLM_p">Compound <b>17</b> was identified as a highly selective M<sub>1</sub> receptor agonist versus M<sub>2</sub>−M<sub>5</sub> and was selected early on as a prototype compound for in-depth profiling and as a benchmark to reference compounds. The fact that a compound does not elicit an agonist response at a receptor does not exclude the possibility that the compound may show antagonistic effects at the receptor, for instance, by binding to inactive receptor conformations. Therefore, we studied the binding of compound <b>17</b> to M<sub>2</sub>−M<sub>5</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) using orthosteric antagonist radioligands and benchmarked to reference compounds. Among the compounds tested, <b>17</b> displayed the least binding to the muscarinic receptor subtypes M<sub>2</sub>−M<sub>5</sub>, making it uniquely selective for the M<sub>1</sub> receptor. In comparison, <b>1</b>, a classical orthosteric M<sub>1</sub> receptor agonist, caused partial activation of the M<sub>4</sub> receptor and, to a lesser extent, activation of M<sub>3</sub> and M<sub>5</sub> receptors as well as binding affinity for the M<sub>2</sub> receptor. Indeed, it has been hypothesized that the M<sub>4</sub> receptor agonism of this compound is responsible for its effects on positive symptoms of schizophrenia.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Furthermore, <b>3</b> showed partial agonism at the M<sub>5</sub> receptor and binding affinity for several muscarinic receptors, suggesting that <b>3</b> has a complex muscarinic pharmacology with mixed agonism and antagonism at different receptor subtypes. Compound <b>2</b> only displayed agonistic activity at the M<sub>1</sub> receptor and weak binding affinity for the M<sub>2</sub>−M<sub>5</sub> receptors, Recently, <b>4</b> was disclosed as a potent and highly subtype selective allosteric M<sub>1</sub> receptor agonist.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In our hands, <b>4</b> showed no agonistic effects at other muscarinic receptors than the M<sub>1</sub>, but the compound did exhibit moderately potent binding affinities at the M<sub>2</sub>−M<sub>4</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities at Muscarinic M<sub>2</sub>−M<sub>5</sub> Receptors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hM<sub>2</sub></th><th class="colsep0 rowsep0" align="center">hM<sub>3</sub></th><th class="colsep0 rowsep0" align="center">hM<sub>4</sub></th><th class="colsep0 rowsep0" align="center">hM<sub>5</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atropine</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2200</td><td class="colsep0 rowsep0" align="left">7000</td><td class="colsep0 rowsep0" align="left">6900</td><td class="colsep0 rowsep0" align="left">8900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">980</td><td class="colsep0 rowsep0" align="left">2800</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">4500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left">430</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">940</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are means of three experiments.</p></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Characterization of Mode of Action of Compound <b>17</b> at the M<sub>1</sub> Receptor</h3><div class="NLM_p">Ca<sup>2+</sup> mobilization is a distal event in the signaling cascade triggered by M<sub>1</sub> receptor activation, and several signaling pathways converge at the point of calcium release. Therefore, we wanted to validate that the observed compound effects were specifically mediated by activation of the muscarinic M<sub>1</sub> receptor. Compound <b>17</b> did not elicit a Ca<sup>2+</sup> mobilization response when assayed on the parental CHO cell line (i.e., not expressing the M<sub>1</sub> receptor; data not shown). The response of the M<sub>1</sub> receptor expressing CHO cell line to <b>17</b> was antagonized by atropine, a competitive muscarinic antagonist, hence demonstrating that the response <b>17</b> was specifically mediated by the M<sub>1</sub> receptor, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration-dependent stimulation of Ca<sup>2+</sup> mobilization in CHO-hM1 cells by ACh (circles) and <b>17</b> (squares, solid line). Antagonism of response to <b>17</b> by 100 nM atropine (squares, dashed line). Data are the mean of three experiments (±SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Classical orthosteric agonists display no saturability in the interaction with an orthosteric antagonist; i.e., the dose−response curves can be right-shifted indefinitely by increasing concentrations of the agonist and antagonist. In a Schild regression plot, this will translate into a slope of unity for orthosteric interaction. Conversely, the action of an allosteric agonist is characterized by saturability of the interaction with an orthosteric antagonist. This relationship translates into a slope that deviates from unity.<a onclick="showRef(event, 'ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref21 ref29">(21, 29)</a> In such a competitive antagonist assay, compound <b>17</b> behaved unlike classical orthosteric agonists like ACh and carbachol (CCh) but competed with atropine in a fashion consistent with an allosteric mode of M<sub>1</sub> receptor activation. The results for <b>17</b> were comparable to those obtained for the allosteric M<sub>1</sub> receptor agonist <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Detection of allosteric agonism by Schild regression: Schild regression for the interaction between the orthosteric antagonist atropine and (A) the orthosteric agonist ACh, (B) the orthosteric agonist carbachol, (C) the allosteric agonist <b>2</b>, and (D) compound. Data are from a cell-based Ca<sup>2+</sup> assay. The dashed lines represent a theoretical Schild regression of unit slope as expected for simple competitive antagonism by atropine. In the experiments with acetylcholine and carbachol, the 95% confidence interval of the slope factor included the unit slope, and the −p<i>K</i><sub>b</sub> for atropine was in the range 9.0−9.6 and, hence, in agreement with literature values (<a href="http://www.iuphar-db.org" class="extLink">www.iuphar-db.org</a>). Shown are representative data from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to further validate the allosteric mode of M<sub>1</sub> receptor activation by <b>17</b>, the compound was assayed for activity at the Y381A mutant M<sub>1</sub> receptor,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in which the essential tyrosine residue 381 located in the transmembrane domain 6 is mutated to alanine. The Y381 residue contributes to the orthosteric binding site of the M<sub>1</sub> receptor, and mutation to alanine has been shown to decrease acetylcholine binding affinity 30-fold and drastically reduce its potency about 3000-fold without affecting efficacy.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The critical contribution of Y381 to the orthosteric site of the M<sub>1</sub> receptor makes the Y381A M<sub>1</sub> receptor mutant a useful tool to detect allosteric agonists. We verified that the Y381A M<sub>1</sub> receptor mutant showed greatly reduced potency with ACh (20000-fold reduction) and CCh, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. To the contrary, the allosteric M<sub>1</sub> receptor agonists <b>2</b> and <b>3</b> showed only minor changes in potency (2-fold reduction and 7-fold increase, respectively), which is in agreement with published results.<a onclick="showRef(event, 'ref19 ref30'); return false;" href="javascript:void(0);" class="ref ref19 ref30">(19, 30)</a> Compound <b>17</b> showed unaltered potency and efficacy at the Y381A M<sub>1</sub> receptor compared to the wild-type M<sub>1</sub> receptor. These data suggest that compound <b>17</b> interacts with the M<sub>1</sub> receptor in a different mode than ACh and, hence, is an allosteric M<sub>1</sub> receptor agonist.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration-dependent stimulation of Ca<sup>2+</sup> mobilization in CHO-K1 hM1-Y381A cells by acetylcholine (solid circles; EC<sub>50</sub> = 27 000 nM, <i>E</i><sub>max</sub> = 100%), <b>17</b> (solid squares; EC<sub>50</sub> = 97 nM; <i>E</i><sub>max</sub> = 82%), <b>2</b> (solid triangles; EC<sub>50</sub> = 500 nM, <i>E</i><sub>max</sub> = 31%), and <b>3</b> (open triangles, EC<sub>50</sub> = 140 nM; <i>E</i><sub>max</sub> = 72%). Data are the mean of three experiments (±SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Broad Selectivity Profiling</h3><div class="NLM_p">Compounds <b>17</b> and <b>2</b> were the two most selective allosteric M<sub>1</sub> receptor agonists and were tested in a broad pharmacology panel screen against 69 receptors, ion channels, transporters, and enzymes. The targets for which <b>17</b> and <b>2</b> showed high to medium affinity (<i>K</i><sub>i</sub> < 1000 nM) are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>17</b> only displayed minor cross-reactivity with other targets, and the most predominant effect was the affinity for the adrenergic α<sub>1A</sub> receptor, at which <b>17</b> had a <i>K</i><sub>i</sub> of 260 nM. In contrast, <b>2</b> displayed a broader pharmacological profile, with affinity to several targets, such as α<sub>1</sub>, dopamine D<sub>2</sub> and D<sub>4</sub>, and serotonin 5-HT<sub>1A</sub> receptors. Thus, the pharmacological profile of <b>2</b> at receptors other than the muscarinic receptor family, in particular such as D<sub>2</sub> but also α<sub>1</sub> receptors, makes it less suitable for use as a tool to study in vivo pharmacological effects of M<sub>1</sub> receptor agonism in in vivo models of schizophrenia. In addition to profiling across the muscarininc M<sub>2</sub>−M<sub>5</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), <b>4</b> was tested in a smaller panel of nine GPCRs of the dopaminergic, histaminergic, adrenergic, and serotonergic receptor families and found to possess α<sub>1</sub> and 5-HT<sub>2C</sub> receptor affinity (for α<sub>1A,B,D</sub>, <i>K</i><sub>i</sub> = 11, 19, and 290 nM, respectively; for 5-HT<sub>2C</sub>, <i>K</i><sub>i</sub> = 85 nM). This also limits the usefulness of this compound as a tool for exploring the effects of M<sub>1</sub> receptor agonism in vivo.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. List of Target Affinities for Which a <i>K</i><sub>i</sub> < 1000 nM Was Obtained from a Panel Screen of <b>17</b> and <b>2</b> on 69 Receptors, Ion Channels, Transporters, and Enzymes<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">Compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Receptor (<i>K</i><sub>i</sub>; nM)</th><th class="colsep0 rowsep0" align="center" char="."><b>17</b></th><th class="colsep0 rowsep0" align="center" char="."><b>2</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hα<sub>1A</sub></td><td class="colsep0 rowsep0" align="char" char=".">260</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hα<sub>1B</sub></td><td class="colsep0 rowsep0" align="char" char=".">910</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hα<sub>1D</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hα<sub>2A</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">530</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hα<sub>2B</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">840</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hD<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hD<sub>4</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hH<sub>1</sub></td><td class="colsep0 rowsep0" align="char" char=".">780</td><td class="colsep0 rowsep0" align="char" char=".">610</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">280</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data are the mean of two determinations.</p></div></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> ADME Properties of <b>17</b></h3><div class="NLM_p">Compound <b>17</b> was investigated for its ADME properties in vitro and in vivo. Moderate plasma protein binding was found in both rats (52%) and humans (72%) following in vitro incubation studies. Intrinsic clearance in rat and human hepatocytes was determined to be 100 mL/min and 3.4 L/min, which is above the hepatic blood flow for both species (rat hepatic blood flow ∼20 mL/min; human hepatic blood flow ∼1.4 L/min). The high intrinsic clearance was in accordance with the observed in vivo pharmacokinetics in rats following intravenous and oral administration, where high systemic clearance and low oral bioavailability (<i>F</i>) was encountered. The plasma concentration−time profile is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, and a summary of the pharmacokinetic parameter estimates is provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The ability of <b>17</b> to penetrate the blood−brain barrier was verified from analysis of plasma and brain homogenate samples after subcutaneous administration. From the AUCs, brain−plasma distribution ratios of 0.35 and 0.20 were found in mice and rats, and the data are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma concentration−time plots of <b>17</b> following intravenous (1 mg/kg) and oral (2 mg/kg) administration in Sprague−Dawley rats. Data shown are the mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma (ng/mL) and brain (ng/g) concentration−time courses of <b>17</b> following subcutaneous administration of 20 mg/kg (C57/6J mice) and 10 mg/kg (Sprague−Dawley rats). Each data point represents an average of <i>n</i> = 3 ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Main Pharmacokinetic Parameters of <b>17</b> after Intravenous (1 mg/kg) and Oral (2 mg/kg) Administration in Rats<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CL<sub>p</sub> ((L/h)/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub>, β (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (po) (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (po) (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.06</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.9</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">4.0 ± 1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Values shown are the average ± SD (<i>n</i> = 3).</p></div></div></div><div class="NLM_p last">When the results from intrinsic clearance, unbound fractions in plasma, and the in vivo clearance in rats were compared, the in vitro/in vivo extrapolated intravenous human hepatic clearance of <b>17</b> was predicted to be around 60 L/h (for a 70 kg subject) and hence below the human hepatic blood flow around 90 L/h. In vitro and in vivo evaluation of the series of analogues of <b>17</b> further suggests the possibility of reducing the human predicted systemic clearance without compromising potency within this series of compounds. For example, compound <b>38</b> was found to have higher stability in human hepatocytes (1.2 L/min) compared to <b>17</b>, which in turn reduces the predicted human clearance by approximately 2-fold.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Effect in an in Vivo Model of Cognition: Delayed Alternation Y-Maze</h3><div class="NLM_p">To examine the effect of <b>17</b> on learning and memory, we tested the compound in the delayed alternation Y-maze task in mice. This task is applied to assess working memory and has previously been shown to be mediated by the prefrontal cortex and the hippocampus across species.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> In the Y-maze version, mice enter the maze from a fixed start arm and are forced to enter one goal arm to collect a reward (“sample run”). During the subsequent run, mice can choose between both goal arms (“choice run”); however, only the arm not entered previously is rewarded. Positive alternation between the two goal arms requires recollection of the previous arm entry, which is intact following a short time delay between the sample and choice run. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, a high degree of positive alternation (>80%), interpreted as intact working memory, was achieved following a short delay (0 s). However, this memory was subject to a time-dependent memory decay, as evident by reduced alternation rates at chance level after a longer intertrail interval (ITI) of 60 s. Animals were treated with <b>17</b> or vehicle 30 min prior to a series of 20 alternation trials, applying both the short and long delay. Following the short delay, vehicle treated animals as well as all dose groups treated with <b>17</b> displayed high correct alternation rates (80−90%, data not shown). As expected, this performance was significantly lower and around chance levels in the vehicle group, following a 60 s delay (55.6 ± 5.3%) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). In contrast, subjects treated with <b>17</b> showed a dose-dependent reversal of the delay-induced memory decay. Whereas pretreatment with lower doses, 0.31 and 1.3 mg/kg <b>17</b>, had no significant effect on alternation rates, groups treated with 10 and 20 mg/kg showed significantly increased levels of positive alternation compared to the vehicle treated group following the 60 s delay. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, systemic treatment of mice with 20 mg/kg <b>17</b> produced high brain exposures during the experiment (440 ± 127 ng/g after 30 min (=pretreatment time) and 240 ± 57 ng/g after 60 min (=end of experiment)). Equilibrium dialysis revealed about 70% nonspecific binding for compound <b>17</b> in mouse brain homogenates, which corresponds to a free concentration of 70 ng/mL (∼170 nM) 60 min after dosing. Free brain concentrations of <b>17</b> were about 3-fold higher than the in vitro EC<sub>50</sub> value (61 nM) during the experiment, suggesting that the procognitive effect was achieved at concentrations that are relevant for an interaction with the M<sub>1</sub> receptor.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>17</b> reverses delay-induced working memory decay in the mouse delayed alternation Y-maze task. The graph shows the percentage of positive alternation of arm entries in successive trial runs following a delay of 1 (“0 sec”) or 60 s. A two-way analysis of variance (ANOVA) with the all pairwise multiple comparison procedure (Student−Newman−Keuls method) revealed an overall difference for factor delay (<i>F</i> = 45.150; <i>p</i> < 0.001) and treatment (<i>F</i> = 5.759; <i>p</i> < 0.001). The vehicle group (black bars) displays a significant decline in correct alternation following the 60 s versus 0 s delay, as well as the low compound <b>17</b> dose groups (white bars) (veh, <i>p</i> < 0.001; 0.31 mg/kg, <i>p</i> < 0.005; 1.3 mg/kg, <i>p</i> < 0.002). Groups treated with 10 and 20 mg/kg <b>17</b> show a dose-dependent, significant increase in correct alternation following the 60 s delay compared to vehicle (10 mg/kg, <i>p</i> < 0.003; 20 mg/kg, <i>p</i> < 0.001). No differences were found between all groups within the 0 s delay (veh vs 0.31 mg/kg, <i>p</i> = 0.152; all others not tested). The dotted line indicates chance performance level (∗, compared to the respective 0 s group; #, compared to the vehicle group at 60 s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These data indicated that <b>17</b> dose-dependently reversed the delay-induced working memory decay in the delayed alternation Y-maze task in mice. Such procognitive effects support a pivotal role of M<sub>1</sub> receptors in learning and memory and a procognitive potential of compound <b>17</b>. A full pharmacological profile of <b>17</b>, including studies in schizophrenia relevant cognition models using perturbed animals, will be reported in a subsequent publication.</div></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have disclosed the discovery and SAR of a novel series of allosteric M<sub>1</sub> receptor agonists. The potent M<sub>1</sub> receptor agonist hit compound <b>5</b> displayed undesired agonistic activity at the M<sub>4</sub> and M<sub>5</sub> receptors and was used as template for SAR investigations. It was revealed that equally potent and efficacious M<sub>1</sub> receptor agonists compounds as <b>5</b> could be found with much improved selectivity with respect to functional agonism at other muscarinic receptor subtypes. Compound <b>17</b> was prioritized within this series as a prototype compound, based on its selectivity for M<sub>1</sub> receptor functional agonism. It was demonstrated that <b>17</b> was an allosteric agonist at the M<sub>1</sub> receptor. In addition to its functional selectivity for the muscarinic M<sub>1</sub> receptor, <b>17</b> also had no binding affinity across the muscarinic receptor subtypes M<sub>2</sub>−M<sub>5</sub>. Likewise, a very limited cross-reactivity was observed toward a panel of 69 receptors, ion channels, transporters, and enzymes. Thus, <b>17</b> has an unprecedented overall selectivity for agonism at the M<sub>1</sub> receptor, making it an excellent compound for investigating the in vivo pharmacology of the M<sub>1</sub> receptor. We tested the compound in an in vivo model of learning and memory in mice and observed a dose-dependent procognitive effect on working memory. In vitro and in vivo characterization supported that <b>17</b> possesses acceptable pharmacokinetic properties. In addition, the potential for improving the metabolic stability within the series was established. Taken together, compound <b>17</b> is a high quality lead for a further drug discovery program aimed at identifying allosteric muscarinic M<sub>1</sub> receptor agonists. A detailed pharmacological profiling of this compound will be reported in a later publication.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Chemistry</h3><div class="NLM_p">The 500 MHz <sup>1</sup>H NMR spectra were recorded on a Bruker Avance AV-III-500 spectrometer. The 600 MHz <sup>1</sup>H NMR spectra were recorded on a Bruker Avance AV-III-600 spectrometer. Chemical shift values are expressed in ppm relative to Me<sub>4</sub>Si.</div><div class="NLM_p">Preparative HPLC purification with MS detection was performed on a Sciex API150ex preparative LC/MS system equipped with a Gilson 333 pump (master) and a Gilson 334 pump (slave) and an Applied Biosystems API150ex single quadrupole mass spectrometer with atmospheric pressure photoionization (APPI) ion source. The purities of the intermediates and final compounds were determined by integration of the UV signal obtained by analytical HPLC−UV−MS on a Sciex API150ex analytical LC/MS system equipped with 3 Shimatsu LC10ADvp LC pumps, a Shimatsu SPD-M20A photodiode array UV detector, and an Applied Biosystems API150ex single quadrupole mass spectrometer with an APPI ion source or by integration of the UV signal obtained by analytical HPLC−UV−MS on a Sciex API300 analytical LC/MS system equipped with 3 Shimatsu LC10ADvp LC pumps, an Acquity UPLC PDA detector with an analytical flow cell, and an Applied Biosystems API300 triple quadrupole mass spectrometer with an APPI ion source.</div><div class="NLM_p">Chromatography was performed on silica gel 60 (230−400 mesh ASTM), Merck.</div><div class="NLM_p">Strong cation exchange (SCX) chromatography columns (Bond-Elut, 500 mg/3 mL) were obtained from Varian.</div><div class="NLM_p">TBD-methylpolystyrene is a polymer-bound version of the strong and highly hindered organic base 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD). The resin was obtained from Novabiochem, loading 2−3 mmol/g.</div><div class="NLM_p">Reagents and solvents obtained from commercial sources were used without additional purification.</div><div class="NLM_p">Xanomeline (<b>1</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> AC-42 (<b>2</b>),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> NDMC (<b>3</b>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and TBTP (<b>4</b>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> were prepared according to the cited literature procedures.</div><div class="NLM_p">The purity of compounds, measured as described above, was >95% unless otherwise stated.</div><div id="sec11_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(2-Fluoro-6-nitrophenyl)propionic Acid (<b>39</b>)</h4><div class="NLM_p last">Sodium hydride (60% oil dispersion) (112 mmol) was suspended in 110 mL of DMF and 50 mL of THF. Diethyl malonate (109 mmol) in 20 mL THF was added dropwise while maintaining the temperature of the reaction mixture below 40 °C. Then the mixture was stirred at ambient temperature for 2 h. 2-Fluoro-6-nitrobenzyl bromide (107 mmol) in 40 mL of DMF and 30 mL of THF was added dropwise while maintaining the temperature of the reaction mixture below 50 °C. The mixture was heated at refluxed for 3 h and then stirred at ambient temperature for 18 h and poured onto brine. The reaction mixture was extracted with ethyl acetate, and the combined organic extracts were dried and evaporated under reduced pressure to yield a red oil. The oil was dissolved in 100 mL of glacial acetic acid, 50 mL of concentrated HCl, and 50 mL of H<sub>2</sub>O and refluxed for 6 h. Then the mixture was stirred at room temperature for 18 h. The solvent was evaporated and the residue triturated with H<sub>2</sub>O. The formed precipitate was filtered off and dissolved in 2 M NaOH and EtOH, each 400 mL. The mixture was refluxed for 40 min. Then the solvent volume was reduced to 500 mL. Ice (300 g) and 4 M HCl were added, to give acidic pH. The aqueous phase was extracted with ethyl acetate, and the organic fractions were combined, washed with brine, dried on MgSO<sub>4</sub>, and evaporated. The crude was obtained as a dark solid and was used without further purification. Crude yield: 79%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 2.55 (t, 2H); 3.04 (t, 2H); 7.52−7.65 (2H); 7.82 (d, 1H); 12.38 (br s, 1H).</div></div><div id="sec11_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-Fluoro-3,4-dihydro-1<i>H</i>-quinolin-2-one (<b>7c</b>)</h4><div class="NLM_p last">Intermediate <b>39</b> (9.4 mmol) was dissolved in 125 mL of MeOH. Then 250 mg of 10% Pd/C and HCOONH<sub>4</sub> (94 mmol) were added. The mixture was refluxed for 45 min. Then the mixture was cooled and filtered. The solvent was removed by evaporation. Toluene (50 mL) was added and removed by evaporation. The residue was partitioned between ethyl acetate and brine, and the aqueous phase was extracted with ethyl acetate. The combined organic fractions were washed with brine, dried, and filtered. The solvent was removed by evaporation, and the product was used without further purification. Crude yield: 96%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 2.47 (t, 2H); 2.87 (t, 2H); 6.70 (d, 1H); 6.77 (m, 1H); 7.16 (m, 1H).</div></div><div id="sec11_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6,7-Difluoro-3,4-dihydro-1<i>H</i>-quinolin-2-one (<b>7g</b>)</h4><div class="NLM_p last">3,4-Difluorophenylamine (250 mmol) was dissolved in 500 mL of ethyl acetate, and triethylamine (300 mmol) was added. 3-Chloropropionyl chloride (275 mmol) was added dropwise while maintaining the temperature below 30 °C. The mixture was stirred at room temperature for 1 h, and then 250 mL of H<sub>2</sub>O was added. The phases were separated, and the organic phase was washed with brine, dried on MgSO<sub>4</sub>, and filtered. The solvent was evaporated and the obtained intermediate (120 mmol) was mixed well with aluminum trichloride (150 mmol) (caution: heating!) in a flask equipped with a washing flask containing 2 M NaOH. The resulting melt was heated at 180 °C for 1 h and then cooled and poured into ice−water. To the mixture were added 25 mL of concentrated HCl and 200 mL of dichloromethane. The obtained solid was recovered by filtration and dried. The crude product was recrystallized from ethyl acetate. Yield: 37%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 2.44 (t, 2H); 2.85 (t, 2H); 6.82 (m, 1H); 7.30 (m, 1H); 10.14 (br s, 1H).</div></div><div id="sec11_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6,7-Difluoro-4<i>H</i>-benzo[1,4]oxazin-3-one (<b>7j</b>)</h4><div class="NLM_p last">4,5-Difluoro-2-nitrophenol (135 mmol) was dissolved in 250 mL of EtOH, and 2 g of 5% Pd/C was added. The mixture was hydrogenated at room temperature for 3 h in a Parr apparatus under 3 bar of H<sub>2</sub>. The catalyst was filtered off and the solvent removed by evaporation. The residue was dissolved in 200 mL of DMF, and chloracetyl chloride (209 mmol) was added with stirring. The mixture was stirred at room temperature for 18 h. Then K<sub>2</sub>CO<sub>3</sub> (360 mmol) was added, and stirring was continued for another 24 h. The solvent was evaporated, and the residue was partitioned between H<sub>2</sub>O and ethyl acetate. The phases were separated. The organic phase was dried on MgSO<sub>4</sub>, and the solvent was removed by evaporation. Purification was by flash chromatography on silica using 40% ethyl acetate in heptane as eluent. Yield: 70%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 4.59 (s, 2H); 6.70 (dd, 1H); 7.15 (dd, 1H); 10.77 (br s, 1H).</div></div><div id="sec11_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(3-Bromopropyl)-4<i>H</i>-benzo[1,4]oxazin-3-one (<b>8a</b>)</h4><div class="NLM_p last">To a suspension of sodium hydride (60% in oil dispersion) (187 mmol) in 75 mL of DMF was added 4<i>H</i>-benzo[1,4]oxazin-3-one (170 mmol) in 100 mL of DMF at 10 °C. The mixture was stirred at room temperature for ∼90 min and then poured into a ice-cooled solution of 1,3-dibromopropane in 100 mL of DMF with vigorous stirring. The mixture was stirred for ∼15 min and then poured into 800 mL of brine. The aqueous phase was extracted with ethyl acetate, and the combined organic extracts were dried on MgSO<sub>4</sub>. After filtration the solvent was removed under reduced pressure and the crude product was purified by flash chromatography on silica using an eluent of 35% ethyl acetate in heptane. Yield: 62%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 2.10 (qui, 2H); 3.59 (t, 2H); 4.02 (t, 2H); 4.65 (s, 2H); 6.99−7.10 (m, 3H); 7.23 (d, 1H).</div></div><div id="sec11_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (<b>17</b>)</h4><div class="NLM_p">Piperidin-4-ylcarbamic acid <i>tert</i>-butyl ester (18 mmol) and <b>8a</b> (18 mmol) were dissolved in 50 mL of MeCN, and K<sub>2</sub>CO<sub>3</sub> (20 mmol) was added. The reaction mixture was stirred at 80 °C for 18 h, then cooled and poured into H<sub>2</sub>O. The aqueous phase was extracted with ethyl acetate, and the combined organic extracts were dried on MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure to yield an oil which was purified by flash chromatography on silica using 50% ethyl acetate in heptane as eluent. The obtained crude was dissolved in dichloromethane, and 15 mL of TFA/H<sub>2</sub>O (95:5) was added. After 20 min, more H<sub>2</sub>O was added and to the solution was added 2 M NaOH to give a pH of ∼12. The aqueous phase was extracted with ethyl acetate, the organic fractions were combined and dried on MgSO<sub>4</sub>, and the solvent was removed by evaporation to yield the intermediate 4-[3-(4-aminopiperidin-1-yl)propyl]-4<i>H</i>-benzo[1,4]oxazin-3-one as an oil. Yield: 50%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 1.36 (m, 2H); 1.66 (m, 2H); 1.75 (m, 2H); 1.88 (t, 2H); 2.29 (t, 2H); 2.72 (m, 1H); 2.79 (m, 2H); 2.84 (t, 2H); 3.44 (m, 2H); 3.88 (t, 2H); 6.99 (t, 1H); 7.14−7.28 (3H).</div><div class="NLM_p last">The obtained intermediate (17 mmol) was dissolved in 60 mL of dry THF, and triethylamine (26 mmol) was added. The mixture was cooled to 5 °C, and phenylacetyl chloride (19 mmol) was added dropwise. The mixture was stirred at room temperature for 1 h and then filtered, and the solvent was removed in vacuo. The crude product was purified by flash chromatography on silica with gradient elution from 80% ethyl acetate in heptane (+5 vol % triethylamine) to 5% EtOH in ethyl acetate (+5 vol % triethylamine). Yield: 64%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz): 1.39 (m, 2H); 1.67−1.73 (4H); 1.91 (t, 2H); 2.30 (t, 2H); 2.75 (m, 2H); 2.37 (s, 2H); 3.48 (m, 1H); 3.92 (t, 2H); 4.62 (s, 2H); 7.01 (d, 2H); 7.06 (m, 1H); 7.18−7.31 (5H); 7.99 (d, 1H).</div></div></div><div id="sec11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biological Methods</h3><div id="sec11_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Cell Lines</h4><div class="NLM_p last">Standard molecular cloning techniques<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> were used to generate the following cell lines: Chinese hamster ovary (CHO-K1) cells expressing either human muscarinic M<sub>1</sub> or M<sub>2</sub> receptor and baby hamster kidney cells (BHK-21) expressing human muscarinic M<sub>3</sub>, M<sub>4</sub>, M<sub>5</sub>, or M<sub>1</sub> Y381A receptors. Cell lines expressing M<sub>2</sub> and M<sub>4</sub> receptors coexpressed the promiscuous G<sub>α16</sub> subunit. The cell line was grown in DMEM or F-12 Kaighn’s medium with <span class="smallcaps smallerCapital">l</span>-glutamine (Gibco), 10% FetalClone I serum (HyClone), and 1% penicillin and streptavidine and supplemented with appropriate antibiotics.</div></div><div id="sec11_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Calcium Mobilization Assays</h4><div class="NLM_p last">Cells expressing muscarinic receptor were plated in growth medium at a density of 10 000 cells/well in clear-bottomed, poly-<span class="smallcaps smallerCapital">d</span>-lysine coated 384-well plates (ArcticWhite LLC) and grown for 24 h at 37 °C in the presence of 5% CO<sub>2</sub>. Before assay, the cells were washed with assay buffer (Hanks’ balanced salt solution with Ca<sup>2+</sup> and Mg<sup>2+</sup> (Gibco) containing 20 mM HEPES, pH 7.4). The cells were incubated with a calcium-sensitive fluorescent dye Calcium4 (Molecular Devices Inc.) with 2.5 mM Probenecid (Sigma) for 50 min at 37 °C followed by 10 min at room temperature. Calcium flux was measured using a Hamamatsu FDSS7000 imaging-based plate reader (Hamamatsu Photonics) using 480 nm excitation light, and emitted fluorescent light passed through a 525 nm emission filter and was detected by a CCD camera. Test compounds were diluted in assay buffer from 2 mM stock solutions in 100% DMSO to give a 3× concentrated stock. Compounds were added to cells and fluorescence was measured at 1 Hz for 6 min starting just prior to compound addition. The fluorescence readout was calculated as max−min response, i.e., maximum fluorescence reading after and before liquid addition. The fluorescence max−min data were normalized to yield responses for no stimulation (buffer) and full stimulation (1 μM acetylcholine) of 0% and 100% stimulation, respectively. Concentration−response data were fitted to the four-parameter logistic equation to estimate compound potency (EC<sub>50</sub>) and efficacy (<i>E</i><sub>max</sub>) of test compounds.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Schild regression experiments were performed by preincubating dye-loaded cells with increasing concentrations of the muscarinic antagonist atropine for 30 min, before the agonist response was assayed as described above. Schild regression analysis was performed by linear fitting to the following model: log(dose ratio − 1) = log([antagonist]) − log(<i>K</i><sub>d</sub>). If the 95% confidence interval of the slope included the value 1.0, the slope was estimated to unity and, hence, the agonist−antagonist interaction was defined as competitive.</div></div><div id="sec11_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Cell Membrane Preparation</h4><div class="NLM_p last">Cells were grown in the appropriate medium to approximately 90% confluence. Cells were washed twice with 10 mL of PBS without Ca<sup>2+</sup>, Mg<sup>2+</sup>, and HCO<sub>3</sub><sup>−</sup>. Cells were harvested in ice cold 20 mM HEPES/10 mM EDTA, pH 7.4, buffer and centrifuged at 3000<i>g</i> for 5 min. Cell pellets were frozen at −80 °C. The thawed pellet was resuspended in 20 mM HEPES/10 mM EDTA buffer, homogenized for 30 s with Ultra-Turrax T25 (IKA-Werke GmbH), and centrifuged at 1000<i>g</i> in 15 min at 4 °C. The supernatant was transferred to a new vial and centrifuged at 40000<i>g</i> for 30 min at 4 °C. The pellet was resuspended in 20 mM HEPES/0.1 mM EDTA, pH 7.4, and centrifuged at 40000<i>g</i> at 4 °C for 30 min. The pellet was resuspended in 20 mM HEPES/0.1 mM EDTA buffer/250 mM sucrose, and 1 mL aliquots were stored at −80 °C. Protein concentration was determined by BCA protein assay kit (Pierce).</div></div><div id="sec11_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Radioligand Binding Assays</h4><div class="NLM_p last">Binding studies were performed by incubating test compound (25 μL), cell membrane preparation (25 μL, typically 5 μg of protein/well) with radioligand (25 μL), and 25 μL of wheat germ agglutinin SPA beads (0.25 mg/well, GE Healthcare) in a white Wallac 96-well isoplate with clear bottom (PerkinElmer). The reagents were mixed for 90 min on an orbital shaker and then centrifuged at 1500 rpm for 5 min at room temperature. Plates were counted in a Wallac TriLux 1450 Microbeta for 2 min/well. Assay buffer was 12.5 mM sodium phosphate buffer with 2 mM NiCl<sub>2</sub>, 2.5 mM MgCl<sub>2</sub>, pH 7.4. The total binding, which comprised less than 5% of added radioligand, was defined by assay buffer, whereas the nonspecific binding was defined in the presence of 1 μM atropine. The nonspecific binding constituted ∼5% of the total binding. The following radioligands were used: M<sub>2</sub>, 3.0 nM <sup>3</sup>H-AFDX-384 (PerkinElmer); M<sub>3</sub>−M<sub>5</sub>, 0.3 nM <sup>3</sup>H-4-DAMP (PerkinElmer). Data points were expressed as percent of the specific binding, and the IC<sub>50</sub> values were determined by nonlinear regression analysis using a sigmoidal variable slope curve fitting. The dissociation constant (<i>K</i><sub>i</sub>) was calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + (<i>L</i>/<i>K</i><sub>d</sub>)), where the concentration of free radioligand <i>L</i> is approximated to the concentration of added radioligand in the assay and <i>K</i><sub>d</sub> equals the affinity of the radioligand to the receptor.</div></div><div id="sec11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Broad Pharmacology Profiling</h4><div class="NLM_p">Broad profiling was performed by CEREP (France). Compounds were generally assayed for the ability to displace radioligand binding to the assayed targets. The following targets were profiled by enzyme assays: PDE3,4,5, Lyn kinase, p38α kinase, and acetylcholine esterase. Compounds were tested at 10 μM, <i>n</i> = 2, at the following targets (CEREP catalog number in parentheses): D<sub>1</sub> (no. 803-1h), D<sub>2S</sub> (no. 803-2h), H<sub>3</sub> (no. 805-3h), rolipram (no. 833), μ (MOP, agonist site) (no. 843-h), MC<sub>4</sub> (no. 889-4h), β<sub>1</sub> (no. 802-2ah), 5-HT<sub>1A</sub> (no. 808-1ah), 5-HT<sub>2B</sub> (agonist site) (no. 808-2bah), 5-HT<sub>2A</sub> (agonist site) (no. 808-2ah), Na<sup>+</sup> channel (site 2) (no. 862-a), H<sub>1</sub> (no. 805-1h), PCP (no. 895-6), glucocorticoid (GR) (no. 812-h), σ (nonselective) (no. 891), D<sub>2S</sub> (agonist site) (no. 803-2ha), M<sub>4</sub> (no. 806-4h), GABA<sub>A</sub> (no. 804-1), α<sub>2A</sub> (no. 802-1bAh), ETA (no. 825-1h), 5-HT<sub>4e</sub> (no. 808-4eh), DA transporter (no. 803-Uh), D<sub>4.4</sub> (no. 803-44h), M<sub>1</sub> (no. 806-1h), α<sub>1</sub> (non-selective) (no. 802-1a), A<sub>1</sub> (no. 801-1h), BZD (central) (no. 851), M<sub>2</sub> (no. 806-2h), M<sub>3</sub> (no. 806-3h)</div><div class="NLM_p last">N (neuronal) (α-BGTX-insensitive) (α<sub>4</sub>β<sub>2</sub>) (no. 807-n1), A<sub>1</sub> (agonist site) (no. 801-1ah), MT<sub>1</sub> (no. 892-1h), Ca<sup>2+</sup> channel (L, diltiazem site) (benzothiazepines) (no. 861-L2), α<sub>2B</sub> (no. 802-1bBc), κ (KOP) (no. 842), 5-HT<sub>2C</sub> (agonist site) (no. 808-8cha), 5-HT<sub>7</sub> (no. 808-7h), D<sub>3</sub> (no. 803-3h), CCKB (CCK2) (no. 824-2h), MAO-A (no. 838-a), β<sub>2</sub> (no. 802-2bh), Ca<sup>2+</sup> channel (L, verapamil site) (phenylalkylamines) (no. 861-L3), H<sub>2</sub> (no. 805-2hc), ML<sub>2</sub> (MT<sub>3</sub>) (no. 892-2), M5 (no. 806-5h), choline transporter (CHT<sub>1</sub>) (no. 806-Uh), I<sub>1</sub> (no. 809-1p), NK<sub>1</sub> (no. 826-1h), Y<sub>1</sub> (no. 827-1h), N (muscle-type) (no. 807-mh), 5-HT transporter (no. 808-Uh), CB<sub>1</sub> (no. 835-ch), 5-HT<sub>1B</sub> (no. 808-1b), NE transporter (no. 802-Uh), Ca<sup>2+</sup> channel (N) (no. 861-N), GABA transporter (no. 804-U), A<sub>3</sub> (no. 801-3h), NK<sub>2</sub> (no. 826-2h), δ<sub>2</sub> (DOP) (no. 841-h), Ca<sup>2+</sup> channel (L, DHP site) (no. 861-L1), 5-HT<sub>3</sub> (no. 808-3h), UT<sub>1</sub> (no. 853-hc), A<sub>2A</sub> (no. 801-2ah).</div></div><div id="sec11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> In Vitro ADME Assays</h4><div id="sec11_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Hepatocyte Clearance Determination</h5><div class="NLM_p last">The intrinsic clearance of compounds in hepatocytes were determined by the <i>t</i><sub>1/2</sub> method,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> i.e., measurement of the disappearance of 1 μM compound over time by LC/MS−MS. Pooled male rat cryopreserved hepatocytes (Sprague−Dawley) and pooled cryopreserved human hepatocytes from 10 donors (male and female) from CellzDirect, Inc., Durham, NC, were used. Cells were thawed in a 37 °C water bath and live cells counted and seeded in a total of 100 μL in Dulbecco’s modified Eagle medium (high glucose) with 5 mM HEPES buffer in 96-well plates. Then 250 000 and 500 000 cells/mL were used for rat and human hepatocytes, respectively. Incubations were started after 15 min of preincubation and stopped at time points 0, 5, 15, 30, and 60 min for rats and 0, 30, 60, 90, and 120 min for human hepatocytes. The <i>t</i><sub>1/2</sub> is scaled to intrinsic clearance values of L/min for humans and mL/min for rats. Values of scaling factors are 135/120 million cells per gram of liver, 45/20 g of liver per kilogram, and standard weight of 0.25/70 kg for rat and human, respectively.</div></div><div id="sec11_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Protein Binding</h5><div class="NLM_p">Plasma protein binding was determined in vitro in rat and human serum following incubation of 0.1 μM test compound dissolved in PBS in ultracentrifugation filter plates (300 μL in each well) (Multiscreen filter plates, 10 kDa MW cutoff, Millipore) for 60 min at 37 °C. Plates were then centrifuged for 60 min at 37 °C (3200 rcf), and the free fraction was measured by LC/MS−MS following addition of internal standard.</div><div class="NLM_p last">Nonspecific binding in brain were obtained by equilibrium dialysis in 96-well format. Freshly isolated mouse brains were homogenized twice in two volumes of phosphate buffer, pH 7.4. The dialysis methodology was modified from ref <a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">37</a>. Membranes (cutoff 12−14 kDa, HTDialysis) was soaked in PBS/ethanol 80:20 and rinsed in deionized water before use. Brain homogenate was spiked with test compound to a final concentration of 1 μM, and equilibrium dialysis was performed by incubating at 37 °C for 5 h. Subsequently, the compound concentration was measured in the buffer phase.</div></div></div><div id="sec11_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> In Vivo ADME Studies</h4><div class="NLM_p">All dosing solutions consisted of 5% HP-β-cyclodextrin, pH 5. Serial blood sampling from the tail vein in awake rats was used for pharmacokinetic assessment following intravenous (1 mg/kg) and oral (2 mg/kg) drug administration. For brain/plasma exposure studies, cardiac blood was obtained under isoflurane anesthesia. Dose volumes of 5 and 10 mL/kg were applied for rats and mice, respectively. Blood samples were collected in EDTA-coated tubes and centrifuged for 10 min at 4 °C after which plasma was drawn off. Following decapitation, the brain was removed and stored at −80 °C pending bioanalysis.</div><div id="sec11_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Plasma and Brain Bioanalysis</h5><div class="NLM_p last">Brain homogenate was prepared by homogenizing the whole brain with 70% acetonitrile (1:4 v/v) followed by centrifugation and collection of the supernatant. Plasma and brain supernatant samples were frozen at −80 °C until analysis. Concentrations of were determined in plasma and brain homogenate using turboflow chromatography (dual column, focus mode, Cohesive Technologies, U.K.) followed by MS/MS detection in positive-ion electrospray ionization mode (Sciex API-3000 MS, Applied Biosystems, The Netherlands). Samples of plasma and brain homogenate were prepared by adding an equal amount of 10% methanol with internal standard included (escitalopram), and after centrifugation (6000<i>g</i>, 5 °C, 20 min) an amount of 10 μL was injected into the turboflow system. The mobile phase consisted of water/methanol with 0.1% ammonium hydroxide pumped as a gradient through an XTerra analytical column (MS C8, 2.1 mm × 20 mm, Waters Corp., MA). The lower limit of quantification was typically 0.5 ng/mL in plasma and 5 ng/g in brain.</div></div></div><div id="sec11_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> In Vitro/in Vivo Extrapolation of Clearance</h4><div class="NLM_p last">According to the well-stirred model,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> an approximate hepatic clearance in each species (CL<sub>pred</sub>) was predicted from hepatocyte intrinsic clearance (CL<sub>int</sub>) according to<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/jm-2010-00697g_m001.gif" alt="" /></img></span>where LBF is hepatic blood flow and <i>f</i><sub>u</sub> is the fraction unbound in serum. Human clearance was then estimated from the observed in vivo rat clearance and the in vitro clearance prediction in each species (CL<sub>pred,human</sub>, CL<sub>pred,rat</sub>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> according to<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/jm-2010-00697g_m002.gif" alt="" /></img></span></div></div><div id="sec11_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Delayed Alternation. Y-Maze</h4><div class="NLM_p">Ten male C57Bl/6J mice (22−24 g, Charles River, Germany) were used for the delayed alternation Y-maze. The maze consisted of gray, nontransparent Plexiglas, shaped to a Y with each arm arranged in 120° to each other and measuring 32 cm × 7 cm × 8 cm. One arm was designated as “start arm”, and the two remaining were “goal arms”. The maze was mounted on an airflow table. Each arm was equipped with a guillotine door allowing restriction to the start arm or providing entrance into each goal arm. Both goal arms were equipped with a small cup at the end of the arm that was baited with 15 μL of chocolate milk (Cocio, Denmark). Before drug testing, subjects were trained to the alternation procedure until an 80% correct alternation rate was reached following the 1s ITI. Subsequently, animals were subjected to drug testing, where 1 s (designated “0 sec”) and 60 s delays were assigned randomly. Subjects were individually placed in the start arm and given a “sample run”, during which one of the goal arms was blocked. Once the subject collected the reward, it was returned manually to the start arm and restricted there for the delay. During the following run (“choice run”) both arms were accessible, but the subject was rewarded only when entering the goal arm opposite that visited during the sample run (i.e., the arm visited during sample run was not rebaited). The animal was returned to the start arm and restricted there for 10 s after which a new trial consisting of sample and choice run started. A total of 20 trials were performed per day and mouse (10 × 0 s delay, 10 × 60 s delay). For drug testing, animals were assigned to a Latin-square design in which each mouse was tested in each dose group over 1 week of testing. Lu AE51090 and vehicle (10% HP-β-cyclodextrin) were dosed subcutaneously in a volume of 5 mL/kg and 30 min before the experiment. Data are expressed as the mean ± SEM. Significant differences between group mean values were assessed by two-way analysis of variance (ANOVA) with the all pairwise multiple comparison procedure (Student−Newman−Keuls method) (SigmaStat 3.0, SPSS).</div><div class="NLM_p last">All in vivo experiments were performed in accordance with Danish legislation, and animals were treated with adherence to guidelines for the care of experimental animals.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/jm100697g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis procedures, spectroscopic data, and purities for intermediates <b>8b</b>−<b>k</b> and compounds <b>5</b>, <b>6</b>, <b>9</b>−<b>16</b>, and <b>18</b>−<b>38</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100697g/suppl_file/jm100697g_si_001.pdf">jm100697g_si_001.pdf (67.72 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100697g" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anette G. Sams</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Research</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0968676c7d7d6c277a68647a49656c66247961687b6468276a6664"><span class="__cf_email__" data-cfemail="5c3d3239282839722f3d312f1c303933712c343d2e313d723f3331">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morten Hentzer</span> - <span class="hlFld-Affiliation affiliation">Molecular Pharmacology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gitte K. Mikkelsen</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krestian Larsen</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoffer Bundgaard</span> - <span class="hlFld-Affiliation affiliation">Discovery ADME</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niels Plath</span> - <span class="hlFld-Affiliation affiliation">In Vivo Neuropharmacology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus T. Christoffersen</span> - <span class="hlFld-Affiliation affiliation">Molecular Pharmacology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benny Bang-Andersen</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry Research</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Caulfield, M. P.</span><span> </span><span class="NLM_article-title">Muscarinic receptors—characterization, coupling, function</span> <span class="citation_source-journal">Pharmacol.Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2F0163-7258%2893%2990027-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=7504306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK2cXlvF0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=319-379&author=M.+P.+Caulfield&title=Muscarinic+receptors%E2%80%94characterization%2C+coupling%2C+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptors-characterization, coupling and function</span></div><div class="casAuthors">Caulfield, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-79</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review, with 558 refs., of muscarinic receptor subtype classification, their localization, distribution, coupling mechanisms and functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkGB9pXvA_rVg90H21EOLACvtfcHk0lixsTFWoQRgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvF0%253D&md5=d57c2e257bd63fb21b719c68cce5826d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2893%2990027-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252893%252990027-B%26sid%3Dliteratum%253Aachs%26aulast%3DCaulfield%26aufirst%3DM.%2BP.%26atitle%3DMuscarinic%2520receptors%25E2%2580%2594characterization%252C%2520coupling%252C%2520function%26jtitle%3DPharmacol.Ther.%26date%3D1993%26volume%3D58%26spage%3D319%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A. J.</span><span> </span><span class="NLM_article-title">Selective loss of central cholinergic neurons in Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1976&pages=1403&author=P.+Daviesauthor=A.+J.+Maloney&title=Selective+loss+of+central+cholinergic+neurons+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520loss%2520of%2520central%2520cholinergic%2520neurons%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1976%26volume%3D2%26spage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Muir, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholine, aging, and Alzheimer’s disease</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=687-696&author=J.+L.+Muir&title=Acetylcholine%2C+aging%2C+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuir%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholine%252C%2520aging%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D56%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=423-450&author=J.+Wess&title=Muscarinic+acetylcholine+receptor+knockout+mice%3A+novel+phenotypes+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptor%2520knockout%2520mice%253A%2520novel%2520phenotypes%2520and%2520clinical%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D44%26spage%3D423%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murpht, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahnama, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span> </span><span class="NLM_article-title">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1038%2Fnn992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12483218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Siurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=51-58&author=S.+G.+Anagnostarasauthor=G.+G.+Murphtauthor=S.+E.+Hamiltonauthor=S.+L.+Mitchellauthor=N.+P.+Rahnamaauthor=N.+M.+Nathansonauthor=A.+J.+Silva&title=Selective+cognitive+dysfunction+in+acetylcholine+M1+muscarinic+receptor+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span></div><div class="casAuthors">Anagnostaras, Stephan G.; Murphy, Geoffrey G.; Hamilton, Susan E.; Mitchell, Scott L.; Rahnama, Nancy P.; Nathanson, Neil M.; Silva, Alcino J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Blockade of cholinergic neurotransmission by muscarinic receptor antagonists produces profound deficits in attention and memory.  However, the antagonists used in previous studies bind to more than one of the five muscarinic receptor subtypes.  Here the authors examd. memory in mice with a null mutation of the gene coding the M1 receptor, the most densely distributed muscarinic receptor in the hippocampus and forebrain.  In contrast with previous studies using nonselective pharmacol. antagonists, the M1 receptor deletion produced a selective phenotype that included both enhancements and deficits in memory.  Long-term potentiation (LTP) in response to theta burst stimulation in the hippocampus was also reduced in mutant mice.  M1 null mutant mice showed normal or enhanced memory for tasks that involved matching-to-sample problems, but they were severely impaired in non-matching-to-sample working memory as well as consolidation.  The authors' results suggest that the M1 receptor is specifically involved in memory processes for which the cortex and hippocampus interact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgA9iYASunfrVg90H21EOLACvtfcHk0li0Jsv59wWlaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Siurs%253D&md5=9b1c1c058c3c2067d37e94653fdc2363</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnn992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn992%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26aulast%3DMurpht%26aufirst%3DG.%2BG.%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRahnama%26aufirst%3DN.%2BP.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520cognitive%2520dysfunction%2520in%2520acetylcholine%2520M1%2520muscarinic%2520receptor%2520mutant%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keriakous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Decreased muscarinic 1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1038%2Fsj.mp.4001199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12476323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1083-1091&author=B.+Deanauthor=M.+McLeodauthor=D.+Keriakousauthor=J.+McKenzieauthor=E.+Scarr&title=Decreased+muscarinic+1+receptors+in+the+dorsolateral+prefrontal+cortex+of+subjects+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span></div><div class="casAuthors">Dean, B.; McLeod, M.; Keriakous, D.; McKenzie, J.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1083-1091</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To test the hypothesis that muscarinic receptors are involved in the pathol. of schizophrenia, we measured muscarinic1 (M1R) and muscarinic4(M4R) protein and mRNA as well as [3H]pirenzepine binding in Brodmann's areas (BA) 9 and 40 obtained postmortem from 20 schizophrenic and 20 age/sex-matched control subjects.  There was a significant decrease in [3H]pirenzepine binding to BA 9 (mean ± SEM: 151 ± 15 vs 195 ± 10 fmol mg-1 ETE; P< 0.02), but not BA 40 (143 ± 13 vs 166 ± 11 fmol mg-1 ETE), from subjects with schizophrenia.  The level of M1R protein (0.11 ± 0.007 vs 0.15 ± 0.008 OD; P < 0.01), but not M4R protein, was decreased in BA9 from schizophrenic subjects with neither receptor protein being altered in BA 40.  The level of M1R mRNA was decreased in BA 9 (30 ± 7.0 vs 79 ± 14 dpm × 103 mg-1ETE, P < 0.01) and BA 40 (28 ± 5.9 vs 99 ± 14, P < 0.01) with schizophrenia but M4R mRNA was only decreased in BA 40 (48 ± 6.6 vs 89 ± 9.9, P < 0.005).  These data suggest that the M1R, at least in the dorsolateral prefrontal cortex, may have a role in the pathol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCGS6ZN-tPSbVg90H21EOLACvtfcHk0li0Jsv59wWlaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D&md5=452f2732469bfcdf46def48079970f80</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001199%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DKeriakous%26aufirst%3DD.%26aulast%3DMcKenzie%26aufirst%3DJ.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DDecreased%2520muscarinic%25201%2520receptors%2520in%2520the%2520dorsolateral%2520prefrontal%2520cortex%2520of%2520subjects%2520with%2520schizophrenia%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D1083%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mancama, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrantz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerwin, R.</span><span> </span><span class="NLM_article-title">Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ht1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2003&pages=2-6&author=D.+Mancamaauthor=M.+J.+Arrantzauthor=S.+Landauauthor=R.+Kerwin&title=Reduced+expression+of+the+muscarinic+1+receptor+cortical+subtype+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia</span></div><div class="casAuthors">Mancama D; Arranz M J; Landau S; Kerwin R</div><div class="citationInfo"><span class="NLM_cas:title">American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">119B</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-6</span>
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    </div><div class="casAbstract">The involvement of specific pathways mediated through muscarinic receptor activity has been widely implicated in schizophrenia.  Extensive pharmacological evidence supports the systems role in mediating antipsychotic drug efficacy, while mounting physiological evidence demonstrates the presence of significant alterations to normal muscarinic receptor integrity in the disorder.  The mechanisms that facilitate the systems involvement and their magnitude, however, remain poorly understood.  We have proposed that alterations to normal muscarinic receptor expression exist in schizophrenia, and that these significantly influence the physiological changes often reported for the system amongst patients.  In this study, we investigate this potential, and have selected to examine the muscarinic 1 receptor, which constitutes a major target for antipsychotic action and plays a conspicuous role in those regions central to the disorders pathophysiology.  Using relative gene quantification, we measured post-mortem levels of steady-state cortical muscarinic 1 receptor cDNA in patients (N = 20) and unaffected controls (N = 20), and examined group differences in expression levels.  Commensurate with our hypothesis, we observed significant reductions in muscarinic 1 receptor cDNA in our patient sample (F(1,37) = 4.73, P = 0.036) and have estimated this to constitute a 28% decrease compared to the control subjects (95% CI from 2 to 47%).  These results provide evidence in support of altered muscarinic 1 receptor expression in schizophrenia, though further work is needed to corroborate these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0Eb6twwtkvkwlCcfExbvbfW6udTcc2eZ16535-Yw15bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ht1Sksg%253D%253D&md5=0be4e0149cd63cfab47415039059817b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DArrantz%26aufirst%3DM.%2BJ.%26aulast%3DLandau%26aufirst%3DS.%26aulast%3DKerwin%26aufirst%3DR.%26atitle%3DReduced%2520expression%2520of%2520the%2520muscarinic%25201%2520receptor%2520cortical%2520subtype%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2003%26volume%3D119%26spage%3D2%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, R.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=R.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0lg_e13UrZbKXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DR.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">Selective targeting of muscarinic receptors: novel therapeutic appraches for psychotic disorders</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.2174%2F1570159052773413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=63-71&author=C.+Surauthor=G.+G.+Kinney&title=Selective+targeting+of+muscarinic+receptors%3A+novel+therapeutic+appraches+for+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of muscarinic receptors: novel therapeutic approaches for psychotic disorders</span></div><div class="casAuthors">Sur, Cyrille; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a well recognized and debilitating psychiatric disorder composed of several symptoms.  Despite the clin. efficacy of present typical and atypical antipsychotics to alleviate pos. symptoms, neg. symptoms and cognitive disorders are not optimally controlled.  Thus, there is an unmet medical need to develop novel medications with improved tolerability and efficacy for the treatment of these symptoms.  Clin. observations over the past 4 decades have accumulated to support a role of central muscarinic cholinergic neurotransmission in psychosis.  Indeed, recent studies have shown that acetylcholine esterase inhibitors as well as weakly selective muscarinic agonists such as xanomeline improved neuropsychiatric symptoms and cognitive function in Alzheimer's disease patients.  Preclinically, a large body of studies has highlighted the involvement of muscarinic cholinergic signaling in cognition and psychosis.  However the lack of truly selective drugs for the 5 muscarinic receptors has prevented an unambiguous detn. of the role of each receptor subtypes in these behaviors.  Recent progress in behavioral studies of mice deficient for the muscarinic receptors and in the discovery of selective muscarinic agonists have started to unravel the contribution of muscarinic receptor subtypes to complex behaviors.  Accordingly, this review examines the potential of selectively targeting muscarinic receptor subtypes as a therapeutic approach for the treatment of psychotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW4bfuXG7EVbVg90H21EOLACvtfcHk0ljxVFKqAxIxsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCru7Y%253D&md5=329942d69a2d06e7362e8a2063d0f15d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1570159052773413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159052773413%26sid%3Dliteratum%253Aachs%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DSelective%2520targeting%2520of%2520muscarinic%2520receptors%253A%2520novel%2520therapeutic%2520appraches%2520for%2520psychotic%2520disorders%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2005%26volume%3D3%26spage%3D63%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sellin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C.</span><span> </span><span class="NLM_article-title">Muscarinic agonists for the treatment of cognition in schizophrenia</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=985-996&author=A.+K.+Sellinauthor=M.+Shadauthor=C.+Tamminga&title=Muscarinic+agonists+for+the+treatment+of+cognition+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSellin%26aufirst%3DA.%2BK.%26aulast%3DShad%26aufirst%3DM.%26aulast%3DTamminga%26aufirst%3DC.%26atitle%3DMuscarinic%2520agonists%2520for%2520the%2520treatment%2520of%2520cognition%2520in%2520schizophrenia%26jtitle%3DCNS%2520Spectrums%26date%3D2008%26volume%3D13%26spage%3D985%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Fischer, A.</span><span> </span><span class="NLM_article-title">Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=433-442&author=A.+Fischer&title=Cholinergic+treatments+with+emphasis+on+m1+muscarinic+agonists+as+potential+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DCholinergic%2520treatments%2520with%2520emphasis%2520on%2520m1%2520muscarinic%2520agonists%2520as%2520potential%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fischer, A.</span><span> </span><span class="NLM_article-title">Muscarinic receptor agonists in Alzheimer’s disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=197-214&author=A.+Fischer&title=Muscarinic+receptor+agonists+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DMuscarinic%2520receptor%2520agonists%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Drugs%26date%3D1999%26volume%3D12%26spage%3D197%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treppendahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A. J.</span><span> </span><span class="NLM_article-title">Novel functional M1 selective muscarinic agonists. Synthesis and structure−activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2274</span><span class="NLM_x">–</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2274-2283&author=P.+Sauerbergauthor=P.+H.+Olesenauthor=S.+Nielsenauthor=S.+Treppendahlauthor=M.+J.+Sheardownauthor=T.+Honoreauthor=C.+H.+Mitchauthor=J.+S.+Wardauthor=A.+J.+Pike&title=Novel+functional+M1+selective+muscarinic+agonists.+Synthesis+and+structure%E2%88%92activity+relationships+of+3-%281%2C2%2C5-thiadiazolyl%29-1%2C2%2C5%2C6-tetrahydro-1-methylpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a019%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DNielsen%26aufirst%3DS.%26aulast%3DTreppendahl%26aufirst%3DS.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26aulast%3DHonore%26aufirst%3DT.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DPike%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520functional%2520M1%2520selective%2520muscarinic%2520agonists.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25203-%25281%252C2%252C5-thiadiazolyl%2529-1%252C2%252C5%252C6-tetrahydro-1-methylpyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2274%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span> </span><span class="NLM_article-title">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioural symptoms in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1001%2Farchneur.1997.00550160091022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=9109749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=465-473&author=N.+C.+Bodickauthor=W.+W.+Offenauthor=A.+I.+Leveyauthor=N.+R.+Cutlerauthor=S.+G.+Gauthierauthor=A.+Satlinauthor=H.+E.+Shannonauthor=G.+D.+Tollefsonauthor=K.+Rasmussenauthor=F.+P.+Bymasterauthor=D.+J.+Hurleyauthor=W.+Z.+Potterauthor=S.+M.+Paul&title=Effects+of+xanomeline%2C+a+selective+muscarinic+receptor+agonist%2C+on+cognitive+function+and+behavioural+symptoms+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span></div><div class="casAuthors">Bodick N C; Offen W W; Levey A I; Cutler N R; Gauthier S G; Satlin A; Shannon H E; Tollefson G D; Rasmussen K; Bymaster F P; Hurley D J; Potter W Z; Paul S M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-73</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the therapeutic effects of selective cholinergic replacement with xanomeline tartrate, an m1 and m4 selective muscarinic receptor (mAChR) agonist in patients with probable Alzheimer disease (AD).  DESIGN:  A 6-month, randomized, double-blind, placebo-controlled, parallel-group trial followed by a 1-month, single-blind, placebo washout.  SETTING:  Outpatients at 17 centers in the United States and Canada.  PARTICIPANTS:  A total of 343 men and women at least 60 years of age with mild to moderate AD.  INTERVENTIONS:  Patients received 75, 150, or 225 mg (low, medium, and high doses) of xanomeline per day or placebo for 6 months.  OUTCOME MEASURES:  Scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog), the Clinician's Interview-Based Impression of Change (CIBIC+), the Alzheimer's Disease Symptomatology Scale (ADSS), and the Nurses' Observational Scale for Geriatric Patients (NOSGER).  RESULTS:  A significant treatment effect existed for ADAS-Cog (high dose vs placebo; P < or = .05), and CIBIC+ (high dose vs placebo; P < or = .02).  Treatment Emergent Signs and Symptoms analysis of the ADSS, which assesses behavioral symptoms in patients with AD, disclosed significant (P < or = .002) dose-dependent reductions in vocal outbursts, suspiciousness, delusions, agitation, and hallucinations.  On end-point analysis, NOSGER, which assesses memory, instrumental activities of daily living, self-care, mood, social behavior, and disturbing behavior in the elderly, also showed a significant dose-response relationship (P < or = .02).  In the high-dose arm, 52% of patients discontinued treatment because of adverse events; dose-dependent adverse events were predominantly gastrointestinal in nature.  Syncope, defined as loss of consciousness and muscle tone, occurred in 12.6% of patients in the high-dose group.  CONCLUSIONS:  The observed improvements in ADAS-Cog and CIBIC+ following treatment with xanomeline provide the first evidence, from a large-scale, placebo-controlled clinical trial, that a direct-acting muscarinic receptor agonist can improve cognitive function in patients with AD.  Furthermore, the dramatic and favorable effects on disturbing behaviors in AD suggest a novel approach for treatment of noncognitive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5beLwC0CkxUGy1nwu7K2mfW6udTcc2eax_0914u28rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D&md5=a1d8d3b2b495133fb37078d387136243</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1997.00550160091022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1997.00550160091022%26sid%3Dliteratum%253Aachs%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DOffen%26aufirst%3DW.%2BW.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DCutler%26aufirst%3DN.%2BR.%26aulast%3DGauthier%26aufirst%3DS.%2BG.%26aulast%3DSatlin%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DTollefson%26aufirst%3DG.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHurley%26aufirst%3DD.%2BJ.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DEffects%2520of%2520xanomeline%252C%2520a%2520selective%2520muscarinic%2520receptor%2520agonist%252C%2520on%2520cognitive%2520function%2520and%2520behavioural%2520symptoms%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1997%26volume%3D54%26spage%3D465%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buelke-Sam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzdak, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, M. D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span> </span><span class="NLM_article-title">Xanomeline: a selective muscarinic agonist for the treatment of Alzherimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=158-170&author=F.+P.+Bymasterauthor=C.+A.+Whitesittauthor=H.+E.+Shannonauthor=N.+DeLappauthor=J.+S.+Wardauthor=D.+O.+Calligaroauthor=L.+A.+Shipleyauthor=J.+L.+Buelke-Samauthor=N.+C.+Bodickauthor=L.+Fardeauthor=M.+J.+Sheardownauthor=P.+H.+Olesenauthor=K.+T.+Hansenauthor=P.+D.+Suzdakauthor=M.+D.+B.+Swedbergauthor=P.+Sauerbergauthor=C.+H.+Mitch&title=Xanomeline%3A+a+selective+muscarinic+agonist+for+the+treatment+of+Alzherimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DWhitesitt%26aufirst%3DC.%2BA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DDeLapp%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DShipley%26aufirst%3DL.%2BA.%26aulast%3DBuelke-Sam%26aufirst%3DJ.%2BL.%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DHansen%26aufirst%3DK.%2BT.%26aulast%3DSuzdak%26aufirst%3DP.%2BD.%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%2BB.%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26atitle%3DXanomeline%253A%2520a%2520selective%2520muscarinic%2520agonist%2520for%2520the%2520treatment%2520of%2520Alzherimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1997%26volume%3D40%26spage%3D158%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Shekar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinckrodt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1176%2Fappi.ajp.2008.06091591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=18593778" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=1033-1039&author=A.+Shekarauthor=W.+Z.+Potterauthor=J.+Lightfootauthor=J.+Lienemannauthor=S.+Dub%C3%A9author=C.+Mallinckrodtauthor=F.+P.+Bymasterauthor=D.+L.+McKinzieauthor=C.+C.+Felder&title=Selective+muscarinic+receptor+agonist+xanomeline+as+a+novel+treatment+approach+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.06091591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.06091591%26sid%3Dliteratum%253Aachs%26aulast%3DShekar%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DLightfoot%26aufirst%3DJ.%26aulast%3DLienemann%26aufirst%3DJ.%26aulast%3DDub%25C3%25A9%26aufirst%3DS.%26aulast%3DMallinckrodt%26aufirst%3DC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520muscarinic%2520receptor%2520agonist%2520xanomeline%2520as%2520a%2520novel%2520treatment%2520approach%2520for%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D1033%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørnholm, B.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of muscarinic agonists: developments since 1990</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1995&pages=37-54&author=E.+K.+Moltzenauthor=B.+Bj%C3%B8rnholm&title=Medicinal+chemistry+of+muscarinic+agonists%3A+developments+since+1990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DBj%25C3%25B8rnholm%26aufirst%3DB.%26atitle%3DMedicinal%2520chemistry%2520of%2520muscarinic%2520agonists%253A%2520developments%2520since%25201990%26jtitle%3DDrugs%2520Future%26date%3D1995%26volume%3D20%26spage%3D37%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Heinrich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paush, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uveges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S. C.</span><span> </span><span class="NLM_article-title">Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M<sub>1</sub>-preferring receptor agonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">605</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2Fj.ejphar.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=19168056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=605&publication_year=2009&pages=53-56&author=J.+N.+Heinrichauthor=J.+A.+Buteraauthor=T.+Carrickauthor=A.+Kramerauthor=D.+Kowalauthor=T.+Lockauthor=K.+L.+Marquisauthor=M.+H.+Paushauthor=M.+Popiolekauthor=S.-C.+Sunauthor=E.+Tsengauthor=A.+J.+Uvegesauthor=S.+C.+Mayer&title=Pharmacological+comparison+of+muscarinic+ligands%3A+historical+versus+more+recent+muscarinic+M1-preferring+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists</span></div><div class="casAuthors">Heinrich, Julia N.; Butera, John A.; Carrick, Tikva; Kramer, Angela; Kowal, Dianne; Lock, Tim; Marquis, Karen L.; Pausch, Mark H.; Popiolek, Mike; Sun, Shaiu-Ching; Tseng, Eugene; Uveges, Albert J.; Mayer, Scott C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">605</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">53-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In functional assay assessments using the five muscarinic receptor subtypes, a second generation of muscarinic M1-preferring receptor agonists [AC-42 (1), AC-260584 (2), 77-LH-28-1 (3) and LY-593039 (4)] was shown to have higher selectivity for muscarinic M1 over M3 receptor as compared to historical agonists [talsaclidine (8), sabcomeline (10), xanomeline (11), WAY-132983 (12), cevimeline (9) and NGX-267 (6)].  Another striking difference of these more recent compds. is their affinities for the dopamine D2 and 5-HT2B receptors.  Taken together, these results suggest that the newer compds. may have a greater clin. safety profile, esp. with regard to muscarinic M3 receptor-mediated events, than the historical agonists, but their affinities for other receptors may still compromise their use to validate the therapeutic potential of muscarinic M1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmMFFxEgbLVg90H21EOLACvtfcHk0liBApc5Ooct9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D&md5=6654ccca50a1db7447e949f5028093dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DCarrick%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DPaush%26aufirst%3DM.%2BH.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26atitle%3DPharmacological%2520comparison%2520of%2520muscarinic%2520ligands%253A%2520historical%2520versus%2520more%2520recent%2520muscarinic%2520M1-preferring%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D605%26spage%3D53%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skjærbæk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span> </span><span class="NLM_article-title">Discovery of an ectopic activation site on the M<sub>1</sub> muscarinic receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=1297-1302&author=T.+A.+Spaldingauthor=C.+Trotterauthor=N.+Skj%C3%A6rb%C3%A6kauthor=T.+L.+Messierauthor=E.+A.+Currierauthor=E.+S.+Bursteinauthor=D.+Liauthor=U.+Hacksellauthor=M.+R.+Brann&title=Discovery+of+an+ectopic+activation+site+on+the+M1+muscarinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DTrotter%26aufirst%3DC.%26aulast%3DSkj%25C3%25A6rb%25C3%25A6k%26aufirst%3DN.%26aulast%3DMessier%26aufirst%3DT.%2BL.%26aulast%3DCurrier%26aufirst%3DE.%2BA.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520an%2520ectopic%2520activation%2520site%2520on%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D1297%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajpai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span> </span><span class="NLM_article-title">Structural requirements of transmembrane domain 3 for activation by the muscarinic receptor agonists AC-42, AC-260484, clozapine, and <i>N</i>-desmethylclozapine: evidence for three distinct modes of receptor activation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1974-1983&author=T.+A.+Spaldingauthor=J.-N.+Maauthor=T.+R.+Ottauthor=M.+Fribergauthor=A.+Bajpaiauthor=S.+R.+Bradleyauthor=R.+E.+Davisauthor=M.+R.+Brannauthor=E.+S.+Burstein&title=Structural+requirements+of+transmembrane+domain+3+for+activation+by+the+muscarinic+receptor+agonists+AC-42%2C+AC-260484%2C+clozapine%2C+and+N-desmethylclozapine%3A+evidence+for+three+distinct+modes+of+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DMa%26aufirst%3DJ.-N.%26aulast%3DOtt%26aufirst%3DT.%2BR.%26aulast%3DFriberg%26aufirst%3DM.%26aulast%3DBajpai%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26atitle%3DStructural%2520requirements%2520of%2520transmembrane%2520domain%25203%2520for%2520activation%2520by%2520the%2520muscarinic%2520receptor%2520agonists%2520AC-42%252C%2520AC-260484%252C%2520clozapine%252C%2520and%2520N-desmethylclozapine%253A%2520evidence%2520for%2520three%2520distinct%2520modes%2520of%2520receptor%2520activation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1974%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span> </span><span class="NLM_article-title">Probing the molecular mechanism of interaction between AC-42 and the muscarinic M<sub>1</sub> receptor: direct pharmacological evidence that AC-42 is an allosteric agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=236-246&author=C.+J.+Langmeadauthor=V.+A.+H.+Fryauthor=I.+T.+Forbesauthor=C.+L.+Branchauthor=A.+Christopoulosauthor=M.+D.+Woodauthor=H.+J.+Herdon&title=Probing+the+molecular+mechanism+of+interaction+between+AC-42+and+the+muscarinic+M1+receptor%3A+direct+pharmacological+evidence+that+AC-42+is+an+allosteric+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DFry%26aufirst%3DV.%2BA.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520molecular%2520mechanism%2520of%2520interaction%2520between%2520AC-42%2520and%2520the%2520muscarinic%2520M1%2520receptor%253A%2520direct%2520pharmacological%2520evidence%2520that%2520AC-42%2520is%2520an%2520allosteric%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D236%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Blatter, F.; Thygesen, M. B.; Tolf, B.-R.; Berghausen, J.</span><span> </span><span class="NLM_article-title">Method of Synthesis and Isolation of Solid <i>N</i>-Desmethylclozapine and Crystalline Forms Thereof</span>. US 2005282800,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Blatter&author=M.+B.+Thygesen&author=B.-R.+Tolf&author=J.+Berghausen&title=Method+of+Synthesis+and+Isolation+of+Solid+N-Desmethylclozapine+and+Crystalline+Forms+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatter%26aufirst%3DF.%26atitle%3DMethod%2520of%2520Synthesis%2520and%2520Isolation%2520of%2520Solid%2520N-Desmethylclozapine%2520and%2520Crystalline%2520Forms%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwango, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breiniger, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5439-5442&author=T.+M.+Bridgesauthor=A.+E.+Bradyauthor=J.+P.+Kennedyauthor=R.+N.+Danielsauthor=N.+R.+Millerauthor=K.+Kwangoauthor=M.+L.+Breinigerauthor=P.+R.+Gentryauthor=J.+T.+Broganauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Synthesis+and+SAR+of+analogues+of+the+M1+allosteric+agonist+TBPB.+Part+I%3A+Exploration+of+alternative+benzyl+and+privileged+structure+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DMiller%26aufirst%3DN.%2BR.%26aulast%3DKwango%26aufirst%3DK.%26aulast%3DBreiniger%26aufirst%3DM.%2BL.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520analogues%2520of%2520the%2520M1%2520allosteric%2520agonist%2520TBPB.%2520Part%2520I%253A%2520Exploration%2520of%2520alternative%2520benzyl%2520and%2520privileged%2520structure%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5439%26epage%3D5442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Motulsky, H.; Christopoulos, A.</span> <span class="citation_source-book">Fitting Models to Biological Data Using Linear and Nonlinear Regression</span>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+Motulsky&author=A.+Christopoulos&title=Fitting+Models+to+Biological+Data+Using+Linear+and+Nonlinear+Regression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%26btitle%3DFitting%2520Models%2520to%2520Biological%2520Data%2520Using%2520Linear%2520and%2520Nonlinear%2520Regression%26pub%3DOxford%2520University%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rowland, M.; Tozer, T. N.</span> <span class="citation_source-book">Clinical Pharmacokinetics: Concepts and Applications</span>; <span class="NLM_publisher-name">Williams and Wilkins</span>: <span class="NLM_publisher-loc">Baltimore, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=M.+Rowland&author=T.+N.+Tozer&title=Clinical+Pharmacokinetics%3A+Concepts+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26btitle%3DClinical%2520Pharmacokinetics%253A%2520Concepts%2520and%2520Applications%26pub%3DWilliams%2520and%2520Wilkins%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigner, B.</span><span> </span><span class="NLM_article-title">Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro−in vivo correlations</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.2165%2F00003088-199936030-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=10223169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK1MXivFSrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=211-231&author=T.+Laveauthor=P.+Coassoloauthor=B.+Reigner&title=Prediction+of+hepatic+metabolic+clearance+based+on+interspecies+allometric+scaling+techniques+and+in+vitro%E2%88%92in+vivo+correlations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations</span></div><div class="casAuthors">Lave, Thierry; Coassolo, Philippe; Reigner, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-231</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 63 refs.  This article reviews the methods available for predicting hepatic metabolic clearance in humans, and discusses their application to the processes of drug discovery and development.  The application of these techniques has increased markedly during the past few years because of the improved availability of human liver samples, which has increased the opportunities to use in vitro studies to predict human clearance.  The techniques available involve both empirical and physiol. based approaches.  Allometric scaling using in vitro data from animals and humans combines certain aspects of both approaches.  An evaluation of data retrieved from the literature indicates that, together with in vitro human data, allometric scaling based on a combination of in vitro and in vivo preclin. data can accurately predict clearance in humans.  With this approach, 80% of the predictions were within a 2-fold factor of actual human clearance values, with an overall accuracy of 1.6-fold.  The uncertainties and inaccuracies in predicting human clearance are related to: (i) the specific method that is used to make the prediction; (ii) the exptl. design and the model used to det. the in vitro clearance; (iii) protein binding within the in vitro test system; and (iv) various in vivo factors such as the involvement of extrahepatic metab. and active transport processes, interindividual variability and nonlinearity in pharmacokinetics.  In contrast to purely empirical approaches, the physiol. approach to predicting clearance gives an opportunity to integrate some of these complexities and, therefore, should provide more confidence in the prediction of clearance in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkMK6ClgApibVg90H21EOLACvtfcHk0lgoqMa0dD6Akw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFSrt74%253D&md5=3764169943504888211b06d3f7e355f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2165%2F00003088-199936030-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199936030-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLave%26aufirst%3DT.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DReigner%26aufirst%3DB.%26atitle%3DPrediction%2520of%2520hepatic%2520metabolic%2520clearance%2520based%2520on%2520interspecies%2520allometric%2520scaling%2520techniques%2520and%2520in%2520vitro%25E2%2588%2592in%2520vivo%2520correlations%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1999%26volume%3D36%26spage%3D211%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mirza, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R. G.</span><span> </span><span class="NLM_article-title">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=159-186&author=N.+R.+Mirzaauthor=D.+Petersauthor=R.+G.+Sparks&title=Xanomeline+and+the+antipsychotic+potential+of+muscarinic+receptor+subtype+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DN.%2BR.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DSparks%26aufirst%3DR.%2BG.%26atitle%3DXanomeline%2520and%2520the%2520antipsychotic%2520potential%2520of%2520muscarinic%2520receptor%2520subtype%2520selective%2520agonists%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. C.</span><span> </span><span class="NLM_article-title">TBPB is a highly selective M<sub>1</sub> allosteric muscarinic receptor agonist in vitro and produces robust antipsychotic-like effects in vivo</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">S116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=S116&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=M.+Bubserauthor=A.+Y.+Deutchauthor=L.+C.+Williams&title=TBPB+is+a+highly+selective+M1+allosteric+muscarinic+receptor+agonist+in+vitro+and+produces+robust+antipsychotic-like+effects+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DWilliams%26aufirst%3DL.%2BC.%26atitle%3DTBPB%2520is%2520a%2520highly%2520selective%2520M1%2520allosteric%2520muscarinic%2520receptor%2520agonist%2520in%2520vitro%2520and%2520produces%2520robust%2520antipsychotic-like%2520effects%2520in%2520vivo%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3DS116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=475-481&author=C.+J.+Langmeadauthor=A.+Christopoulos&title=Allosteric+agonists+of+7TM+receptors%3A+expanding+the+pharmacological+toolbox"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520agonists%2520of%25207TM%2520receptors%253A%2520expanding%2520the%2520pharmacological%2520toolbox%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D475%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallorga, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandish, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolnick, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate recetor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13674</span><span class="NLM_x">–</span> <span class="NLM_lpage">13679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13674-13679&author=C.+Surauthor=P.+J.+Mallorgaauthor=M.+Wittmannauthor=M.+A.+Jacobsonauthor=D.+Pascarellaauthor=J.+B.+Williamsauthor=P.+E.+Brandishauthor=D.+J.+Pettiboneauthor=E.+M.+Scolnickauthor=P.+J.+Conn&title=N-Desmethylclozapine%2C+an+allosteric+agonist+at+muscarinic+1+receptor%2C+potentiates+N-methyl-d-aspartate+recetor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DScolnick%26aufirst%3DE.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DN-Desmethylclozapine%252C%2520an%2520allosteric%2520agonist%2520at%2520muscarinic%25201%2520receptor%252C%2520potentiates%2520N-methyl-d-aspartate%2520recetor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13674%26epage%3D13679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Aultman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghaddam, B.</span><span> </span><span class="NLM_article-title">Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=353-364&author=J.+M.+Aultmanauthor=B.+Moghaddam&title=Distinct+contributions+of+glutamate+and+dopamine+receptors+to+temporal+aspects+of+rodent+working+memory+using+a+clinically+relevant+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAultman%26aufirst%3DJ.%2BM.%26aulast%3DMoghaddam%26aufirst%3DB.%26atitle%3DDistinct%2520contributions%2520of%2520glutamate%2520and%2520dopamine%2520receptors%2520to%2520temporal%2520aspects%2520of%2520rodent%2520working%2520memory%2520using%2520a%2520clinically%2520relevant%2520task%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D153%26spage%3D353%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisog, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerleider, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haxby, J. V.</span><span> </span><span class="NLM_article-title">An area specialized for spatial working memory in human frontal cortex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1347-1351&author=S.+M.+Courtneyauthor=L.+Petitauthor=J.+M.+Maisogauthor=L.+G.+Ungerleiderauthor=J.+V.+Haxby&title=An+area+specialized+for+spatial+working+memory+in+human+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DPetit%26aufirst%3DL.%26aulast%3DMaisog%26aufirst%3DJ.%2BM.%26aulast%3DUngerleider%26aufirst%3DL.%2BG.%26aulast%3DHaxby%26aufirst%3DJ.%2BV.%26atitle%3DAn%2520area%2520specialized%2520for%2520spatial%2520working%2520memory%2520in%2520human%2520frontal%2520cortex%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kesner, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span> </span><span class="NLM_article-title">Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1093%2Fcercor%2F6.2.311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=8670659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADyaK283ovVKhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=311-318&author=R.+P.+Kesnerauthor=M.+E.+Huntauthor=J.+M.+Williamsauthor=J.+M.+Long&title=Prefrontal+cortex+and+working+memory+for+spatial+response%2C+spatial+location%2C+and+visual+object+information+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat</span></div><div class="casAuthors">Kesner R P; Hunt M E; Williams J M; Long J M</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-8</span>
        ISSN:<span class="NLM_cas:issn">1047-3211</span>.
    </div><div class="casAbstract">In the first experiment, rats were trained on a working memory task for a spatial response (right-left turn) information using a delayed matching-to-sample procedure.  Following lesions of the medial prefrontal cortex (MPF), which includes anterior cingulate and medial precentral cortex, there was a profound working memory deficit even at the shortest delay.  In the second experiment, rats were trained on a working memory task for spatial location information using a delayed matching-to-sample procedure.  Following lesions of the MPF, there was only a mild working memory deficit, whereas following dorsal hippocampal lesions there was a profound working memory deficit even at the shortest delay.  In the third experiment, rats were trained on a working memory task for visual object information using a delayed nonmatching-to-sample procedure.  Following lesions of the MPF, there were no working memory deficits, whereas following lesions of the prelimbic and infralimbic cortex there was a profound working memory deficit even at the shortest delay.  The results suggest that different neural subregions of the prefrontal cortex mediate working memory for specific attribute information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTybPSPs4y1npw7prLlxLOzfW6udTcc2eZDAdfYzltuXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283ovVKhsQ%253D%253D&md5=c1b10733743b2ad91adea203e957d1bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2F6.2.311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252F6.2.311%26sid%3Dliteratum%253Aachs%26aulast%3DKesner%26aufirst%3DR.%2BP.%26aulast%3DHunt%26aufirst%3DM.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26atitle%3DPrefrontal%2520cortex%2520and%2520working%2520memory%2520for%2520spatial%2520response%252C%2520spatial%2520location%252C%2520and%2520visual%2520object%2520information%2520in%2520the%2520rat%26jtitle%3DCereb.%2520Cortex%26date%3D1996%26volume%3D6%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Brann, M.; Messier, T.; Currier, E.; Duggento, K.; Friberg, M.; Skjærbæk, N.; Spalding, T.</span><span> </span><span class="NLM_article-title">Compounds with activity on muscarinic receptors</span>, WO200105763,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+Brann&author=T.+Messier&author=E.+Currier&author=K.+Duggento&author=M.+Friberg&author=N.+Skj%C3%A6rb%C3%A6k&author=T.+Spalding&title=Compounds+with+activity+on+muscarinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrann%26aufirst%3DM.%26atitle%3DCompounds%2520with%2520activity%2520on%2520muscarinic%2520receptors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sambrook, J.; Fritsch, E. F.; Maniastis, T.</span> <span class="citation_source-book">Molecular Cloning: A Laboratory Manual</span>; <span class="NLM_publisher-name">Cold Spring Harbor Laboratory Press</span>: <span class="NLM_publisher-loc">Cold Spring Harbor, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=J.+Sambrook&author=E.+F.+Fritsch&author=T.+Maniastis&title=Molecular+Cloning%3A+A+Laboratory+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSambrook%26aufirst%3DJ.%26btitle%3DMolecular%2520Cloning%253A%2520A%2520Laboratory%2520Manual%26pub%3DCold%2520Spring%2520Harbor%2520Laboratory%2520Press%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lim5POmCBSuGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lim5POmCBSuGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, Riccardo Petrelli, Alessandro Piergentili, Stefano Fontana, Valerio Mammoli, Hideaki Yano, Rosanna Matucci, Giulio Vistoli, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3712-3725. <a href="https://doi.org/10.1021/acs.jmedchem.8b00265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-%25255B3-%2525284-Butylpiperidin-1-yl%252529propyl%25255D-1%25252C2%25252C3%25252C4-tetrahydroquinolin-2-one%252B%25252877-LH-28-1%252529%252Bas%252Ba%252BModel%252Bfor%252Bthe%252BRational%252BDesign%252Bof%252Ba%252BNovel%252BClass%252Bof%252BBrain%252BPenetrant%252BLigands%252Bwith%252BHigh%252BAffinity%252Band%252BSelectivity%252Bfor%252BDopamine%252BD4%252BReceptor%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D06042018%26date%3D28032018%26volume%3D61%26issue%3D8%26spage%3D3712%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Classics in Chemical Neuroscience: Xanomeline. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 435-443. <a href="https://doi.org/10.1021/acschemneuro.7b00001" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00001%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DClassics%252Bin%252BChemical%252BNeuroscience%25253A%252BXanomeline%26aulast%3DBender%26aufirst%3DAaron%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04012017%26date%3D31012017%26date%3D13022017%26date%3D15032017%26date%3D31012017%26volume%3D8%26issue%3D3%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Herman D.  Lim</span>, <span class="hlFld-ContribAuthor ">Carmen  Klein Herenbrink</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, and <span class="hlFld-ContribAuthor ">Ben  Capuano</span>  . </span><span class="cited-content_cbyCitation_article-title">Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1550-1555. <a href="https://doi.org/10.1021/jm5013243" title="DOI URL">https://doi.org/10.1021/jm5013243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5013243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5013243%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProof%252Bof%252BConcept%252BStudy%252Bfor%252BDesigned%252BMultiple%252BLigands%252BTargeting%252Bthe%252BDopamine%252BD2%25252C%252BSerotonin%252B5-HT2A%25252C%252Band%252BMuscarinic%252BM1%252BAcetylcholine%252BReceptors%26aulast%3DSzabo%26aufirst%3DMonika%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D29082014%26date%3D30012015%26date%3D12022015%26date%3D15012015%26volume%3D58%26issue%3D3%26spage%3D1550%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Aniket  Farande</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>, <span class="hlFld-ContribAuthor ">Riccardo  Petrelli</span>, <span class="hlFld-ContribAuthor ">Rosanna  Matucci</span>, <span class="hlFld-ContribAuthor ">Marta  Nesi</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Sergi  Ferré</span>, and <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 9065-9077. <a href="https://doi.org/10.1021/jm501173q" title="DOI URL">https://doi.org/10.1021/jm501173q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501173q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501173q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BHeterobivalent%252BMuscarinic%252BLigands%252BBased%252Bon%252BXanomeline%252Band%252B1-%25255B3-%2525284-Butylpiperidin-1-yl%252529propyl%25255D-1%25252C2%25252C3%25252C4-tetrahydroquinolin-2-one%252B%25252877-LH-28-1%252529%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31072014%26date%3D16102014%26date%3D13112014%26date%3D02102014%26volume%3D57%26issue%3D21%26spage%3D9065%26epage%3D9077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Briana J.  Davie</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, and <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of M1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (7)
                                     , 1026-1048. <a href="https://doi.org/10.1021/cn400086m" title="DOI URL">https://doi.org/10.1021/cn400086m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400086m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400086m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDevelopment%252Bof%252BM1%252BmAChR%252BAllosteric%252Band%252BBitopic%252BLigands%25253A%252BProspective%252BTherapeutics%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDeficits%26aulast%3DDavie%26aufirst%3DBriana%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11042013%26date%3D09052013%26date%3D23052013%26date%3D17072013%26date%3D09052013%26volume%3D4%26issue%3D7%26spage%3D1026%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine B.  Daval</span>, <span class="hlFld-ContribAuthor ">Céline  Valant</span>, <span class="hlFld-ContribAuthor ">Dominique  Bonnet</span>, <span class="hlFld-ContribAuthor ">Esther  Kellenberger</span>, <span class="hlFld-ContribAuthor ">Marcel  Hibert</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Galzi</span>, and <span class="hlFld-ContribAuthor ">Brigitte  Ilien</span>  . </span><span class="cited-content_cbyCitation_article-title">Fluorescent Derivatives of AC-42 To Probe Bitopic Orthosteric/Allosteric Binding Mechanisms on Muscarinic M1 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2125-2143. <a href="https://doi.org/10.1021/jm201348t" title="DOI URL">https://doi.org/10.1021/jm201348t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201348t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201348t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorescent%252BDerivatives%252Bof%252BAC-42%252BTo%252BProbe%252BBitopic%252BOrthosteric%25252FAllosteric%252BBinding%252BMechanisms%252Bon%252BMuscarinic%252BM1%252BReceptors%26aulast%3DDaval%26aufirst%3DSandrine%2BB.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D08102011%26date%3D27022012%26date%3D08032012%26date%3D14022012%26volume%3D55%26issue%3D5%26spage%3D2125%26epage%3D2143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandhya  Jonnala</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Nameta</span>, <span class="hlFld-ContribAuthor ">Murthy  Chavali</span>, <span class="hlFld-ContribAuthor ">Rajashaker  Bantu</span>, <span class="hlFld-ContribAuthor ">Pallavi  Choudante</span>, <span class="hlFld-ContribAuthor ">Sunil  Misra</span>, <span class="hlFld-ContribAuthor ">B.  Sridhar</span>, <span class="hlFld-ContribAuthor ">S.  Dilip</span>, <span class="hlFld-ContribAuthor ">B.V. Subba  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Molecular Docking and Biological Evaluation of  1-(benzo[d]thiazol-2-ylamino)(phenyl)methyl)naphthalen-2-ol Derivatives as Antiproliferative Agents. </span><span class="cited-content_cbyCitation_journal-name">Letters in Organic Chemistry</span><span> <strong>2019,</strong> <em>16 </em>
                                    (10)
                                     , 837-845. <a href="https://doi.org/10.2174/1570178616666190408101233" title="DOI URL">https://doi.org/10.2174/1570178616666190408101233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570178616666190408101233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570178616666190408101233%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Organic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BMolecular%252BDocking%252Band%252BBiological%252BEvaluation%252Bof%252B1-%252528benzo%25255Bd%25255Dthiazol-2-ylamino%252529%252528phenyl%252529methyl%252529naphthalen-2-ol%252BDerivatives%252Bas%252BAntiproliferative%252BAgents%26aulast%3DJonnala%26aufirst%3DSandhya%26date%3D2019%26volume%3D16%26issue%3D10%26spage%3D837%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Volpato</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3230. <a href="https://doi.org/10.3390/molecules23123230" title="DOI URL">https://doi.org/10.3390/molecules23123230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123230%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesigning%252BHybrids%252BTargeting%252Bthe%252BCholinergic%252BSystem%252Bby%252BModulating%252Bthe%252BMuscarinic%252Band%252BNicotinic%252BReceptors%25253A%252BA%252BConcept%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DVolpato%26aufirst%3DDaniela%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. V.  Anis’kova</span>, <span class="hlFld-ContribAuthor ">A. Yu.  Egorova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Substituted Pyridazin-3-ones, 1,2-Oxazin-3-ones, and Furopyrimidines from (Arylmethylidene)furan-2(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>54 </em>
                                    (9)
                                     , 1389-1394. <a href="https://doi.org/10.1134/S1070428018090208" title="DOI URL">https://doi.org/10.1134/S1070428018090208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428018090208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428018090208%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BSubstituted%252BPyridazin-3-ones%25252C%252B1%25252C2-Oxazin-3-ones%25252C%252Band%252BFuropyrimidines%252Bfrom%252B%252528Arylmethylidene%252529furan-2%2525283H%252529-ones%26aulast%3DAnis%25E2%2580%2599kova%26aufirst%3DT.%2BV.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D9%26spage%3D1389%26epage%3D1394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Bock</span>, <span class="hlFld-ContribAuthor ">Ramona  Schrage</span>, <span class="hlFld-ContribAuthor ">Klaus  Mohr</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting CNS muscarinic receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>136 </em>, 427-437. <a href="https://doi.org/10.1016/j.neuropharm.2017.09.024" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BCNS%252Bmuscarinic%252Breceptors%26aulast%3DBock%26aufirst%3DAndreas%26date%3D2018%26volume%3D136%26spage%3D427%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Т.В.  Аниськова</span>, <span class="hlFld-ContribAuthor ">А.Ю.  Егорова</span>. </span><span class="cited-content_cbyCitation_article-title">СИНТЕЗ ЗАМЕЩЕННЫХ ПИРИДАЗИН-3-ОНОВ, ОКСАЗИН-2-ОНОВ И ФУРОПИРИМИДИНОВ НА ОСНОВЕ (АРИЛМЕТИЛИДЕН)-ФУРАН-2(3Д)-ОНОВ, "Журнал органической химии". </span><span class="cited-content_cbyCitation_journal-name">Журнал органической химии</span><span> <strong>2018,</strong> <em> </em>
                                    (9)
                                     , 1374-1379. <a href="https://doi.org/10.7868/S0514749218090200" title="DOI URL">https://doi.org/10.7868/S0514749218090200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7868/S0514749218090200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7868%2FS0514749218090200%26sid%3Dliteratum%253Aachs%26jtitle%3D%25D0%2596%25D1%2583%25D1%2580%25D0%25BD%25D0%25B0%25D0%25BB%2520%25D0%25BE%25D1%2580%25D0%25B3%25D0%25B0%25D0%25BD%25D0%25B8%25D1%2587%25D0%25B5%25D1%2581%25D0%25BA%25D0%25BE%25D0%25B9%2520%25D1%2585%25D0%25B8%25D0%25BC%25D0%25B8%25D0%25B8%26atitle%3D%2525D0%2525A1%2525D0%252598%2525D0%25259D%2525D0%2525A2%2525D0%252595%2525D0%252597%252B%2525D0%252597%2525D0%252590%2525D0%25259C%2525D0%252595%2525D0%2525A9%2525D0%252595%2525D0%25259D%2525D0%25259D%2525D0%2525AB%2525D0%2525A5%252B%2525D0%25259F%2525D0%252598%2525D0%2525A0%2525D0%252598%2525D0%252594%2525D0%252590%2525D0%252597%2525D0%252598%2525D0%25259D-3-%2525D0%25259E%2525D0%25259D%2525D0%25259E%2525D0%252592%25252C%252B%2525D0%25259E%2525D0%25259A%2525D0%2525A1%2525D0%252590%2525D0%252597%2525D0%252598%2525D0%25259D-2-%2525D0%25259E%2525D0%25259D%2525D0%25259E%2525D0%252592%252B%2525D0%252598%252B%2525D0%2525A4%2525D0%2525A3%2525D0%2525A0%2525D0%25259E%2525D0%25259F%2525D0%252598%2525D0%2525A0%2525D0%252598%2525D0%25259C%2525D0%252598%2525D0%252594%2525D0%252598%2525D0%25259D%2525D0%25259E%2525D0%252592%252B%2525D0%25259D%2525D0%252590%252B%2525D0%25259E%2525D0%2525A1%2525D0%25259D%2525D0%25259E%2525D0%252592%2525D0%252595%252B%252528%2525D0%252590%2525D0%2525A0%2525D0%252598%2525D0%25259B%2525D0%25259C%2525D0%252595%2525D0%2525A2%2525D0%252598%2525D0%25259B%2525D0%252598%2525D0%252594%2525D0%252595%2525D0%25259D%252529-%2525D0%2525A4%2525D0%2525A3%2525D0%2525A0%2525D0%252590%2525D0%25259D-2%2525283%2525D0%252594%252529-%2525D0%25259E%2525D0%25259D%2525D0%25259E%2525D0%252592%25252C%252B%252522%2525D0%252596%2525D1%252583%2525D1%252580%2525D0%2525BD%2525D0%2525B0%2525D0%2525BB%252B%2525D0%2525BE%2525D1%252580%2525D0%2525B3%2525D0%2525B0%2525D0%2525BD%2525D0%2525B8%2525D1%252587%2525D0%2525B5%2525D1%252581%2525D0%2525BA%2525D0%2525BE%2525D0%2525B9%252B%2525D1%252585%2525D0%2525B8%2525D0%2525BC%2525D0%2525B8%2525D0%2525B8%252522%26aulast%3D%25D0%2590%25D0%25BD%25D0%25B8%25D1%2581%25D1%258C%25D0%25BA%25D0%25BE%25D0%25B2%25D0%25B0%26aufirst%3D%25D0%25A2.%25D0%2592.%26date%3D2018%26issue%3D9%26spage%3D1374%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhong</span>, <span class="hlFld-ContribAuthor ">Shi-Long  Zheng</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>, <span class="hlFld-ContribAuthor ">Guang-Di  Wang</span>, <span class="hlFld-ContribAuthor ">Ling  He</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselective synthesis and cytotoxic activity of a series of novel benzo[1,4]oxazin-3-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1243-1247. <a href="https://doi.org/10.1016/j.cclet.2016.12.028" title="DOI URL">https://doi.org/10.1016/j.cclet.2016.12.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2016.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2016.12.028%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DChemoselective%252Bsynthesis%252Band%252Bcytotoxic%252Bactivity%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bbenzo%25255B1%25252C4%25255Doxazin-3-one%252Bderivatives%26aulast%3DWang%26aufirst%3DPeng%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1243%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramineni  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Suresh  Kasaboina</span>, <span class="hlFld-ContribAuthor ">Deepthi  Bidayat</span>, <span class="hlFld-ContribAuthor ">U  Nikhil Kumar</span>, <span class="hlFld-ContribAuthor ">Nishant  Jain</span>, <span class="hlFld-ContribAuthor ">Saritha Jostna  Tangeda</span>, <span class="hlFld-ContribAuthor ">Rajashaker  Bantu</span>, <span class="hlFld-ContribAuthor ">Sridhara  Janardhan</span>, <span class="hlFld-ContribAuthor ">Lingaiah  Nagarapu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzothiazine-piperazine derivatives by peptide-coupling as potential anti-proliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 354-359. <a href="https://doi.org/10.1016/j.bmcl.2016.10.071" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.071%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bbenzothiazine-piperazine%252Bderivatives%252Bby%252Bpeptide-coupling%252Bas%252Bpotential%252Banti-proliferative%252Bagents%26aulast%3DVenkatesh%26aufirst%3DRamineni%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D354%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Welt</span>, <span class="hlFld-ContribAuthor ">Luka  Kulic</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Hoey</span>, <span class="hlFld-ContribAuthor ">Jordan  McAfoose</span>, <span class="hlFld-ContribAuthor ">Claudia  Späni</span>, <span class="hlFld-ContribAuthor ">Antonella Santuccione  Chadha</span>, <span class="hlFld-ContribAuthor ">Abraham  Fisher</span>, <span class="hlFld-ContribAuthor ">Roger M.  Nitsch</span>. </span><span class="cited-content_cbyCitation_article-title">Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2015,</strong> <em>46 </em>
                                    (4)
                                     , 971-982. <a href="https://doi.org/10.3233/JAD-150152" title="DOI URL">https://doi.org/10.3233/JAD-150152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-150152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-150152%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DAcute%252BEffects%252Bof%252BMuscarinic%252BM1%252BReceptor%252BModulation%252Bon%252BA%2525CE%2525B2PP%252BMetabolism%252Band%2525C2%2525A0Amyloid-%2525CE%2525B2%252BLevels%252Bin%252Bvivo%25253A%252BA%2525C2%2525A0Microdialysis%252BStudy%26aulast%3DWelt%26aufirst%3DTobias%26date%3D2015%26volume%3D46%26issue%3D4%26spage%3D971%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takaaki  Sumiyoshi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Enomoto</span>. </span><span class="cited-content_cbyCitation_article-title">Muscarinic Acetylcholine Receptor Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 183-211. <a href="https://doi.org/10.1007/7355_2014_47" title="DOI URL">https://doi.org/10.1007/7355_2014_47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_47%26sid%3Dliteratum%253Aachs%26atitle%3DMuscarinic%252BAcetylcholine%252BReceptor%252BActivators%26aulast%3DSumiyoshi%26aufirst%3DTakaaki%26date%3D2014%26date%3D2014%26spage%3D183%26epage%3D211%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce J.  Melancon</span>, <span class="hlFld-ContribAuthor ">James C.  Tarr</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Panarese</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (23-24)
                                     , 1185-1199. <a href="https://doi.org/10.1016/j.drudis.2013.09.005" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAllosteric%252Bmodulation%252Bof%252Bthe%252BM1%252Bmuscarinic%252Bacetylcholine%252Breceptor%25253A%252Bimproving%252Bcognition%252Band%252Ba%252Bpotential%252Btreatment%252Bfor%252Bschizophrenia%252Band%252BAlzheimer%252527s%252Bdisease%26aulast%3DMelancon%26aufirst%3DBruce%2BJ.%26date%3D2013%26volume%3D18%26issue%3D23-24%26spage%3D1185%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen P.H.  Alexander</span>, <span class="hlFld-ContribAuthor ">Helen E.  Benson</span>, <span class="hlFld-ContribAuthor ">Elena  Faccenda</span>, <span class="hlFld-ContribAuthor ">Adam J.  Pawson</span>, <span class="hlFld-ContribAuthor ">Joanna L.  Sharman</span>, <span class="hlFld-ContribAuthor ">Michael  Spedding</span>, <span class="hlFld-ContribAuthor ">John A.  Peters</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Harmar</span>, . </span><span class="cited-content_cbyCitation_article-title">The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (8)
                                     , 1459-1581. <a href="https://doi.org/10.1111/bph.12445" title="DOI URL">https://doi.org/10.1111/bph.12445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12445%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252BConcise%252BGuide%252Bto%252BPHARMACOLOGY%252B2013%25252F14%25253A%252BG%252BProtein-Coupled%252BReceptors%26aulast%3DAlexander%26aufirst%3DStephen%2BP.H.%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D8%26spage%3D1459%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew Stuart  Gibbons</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Scarr</span>, <span class="hlFld-ContribAuthor ">Simone  Boer</span>, <span class="hlFld-ContribAuthor ">Tammie  Money</span>, <span class="hlFld-ContribAuthor ">Won-Je  Jeon</span>, <span class="hlFld-ContribAuthor ">Chris  Felder</span>, <span class="hlFld-ContribAuthor ">Brian  Dean</span>. </span><span class="cited-content_cbyCitation_article-title">Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2013,</strong> <em>16 </em>
                                    (1)
                                     , 37-46. <a href="https://doi.org/10.1017/S1461145712000028" title="DOI URL">https://doi.org/10.1017/S1461145712000028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S1461145712000028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS1461145712000028%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DWidespread%252Bdecreases%252Bin%252Bcortical%252Bmuscarinic%252Breceptors%252Bin%252Ba%252Bsubset%252Bof%252Bpeople%252Bwith%252Bschizophrenia%26aulast%3DGibbons%26aufirst%3DAndrew%2BStuart%26date%3D2013%26date%3D2013%26volume%3D16%26issue%3D1%26spage%3D37%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott D  Kuduk</span>, <span class="hlFld-ContribAuthor ">Douglas C  Beshore</span>. </span><span class="cited-content_cbyCitation_article-title">Novel M
              1
              allosteric ligands: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 1385-1398. <a href="https://doi.org/10.1517/13543776.2012.731395" title="DOI URL">https://doi.org/10.1517/13543776.2012.731395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.731395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.731395%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252BM%252B1%252Ballosteric%252Bligands%25253A%252Ba%252Bpatent%252Breview%26aulast%3DKuduk%26aufirst%3DScott%2BD%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D1385%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anette Graven  Sams</span>, <span class="hlFld-ContribAuthor ">Krestian  Larsen</span>, <span class="hlFld-ContribAuthor ">Gitte Kobberøe  Mikkelsen</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Claus Tornby  Christoffersen</span>, <span class="hlFld-ContribAuthor ">Klaus Gjervig  Jensen</span>, <span class="hlFld-ContribAuthor ">Kristen  Frederiksen</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (15)
                                     , 5134-5140. <a href="https://doi.org/10.1016/j.bmcl.2012.05.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHit-to-lead%252Binvestigation%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bcombined%252Bdopamine%252BD2%252Band%252Bmuscarinic%252BM1%252Breceptor%252Bligands%252Bwith%252Bputative%252Bantipsychotic%252Band%252Bpro-cognitive%252Bpotential%26aulast%3DSams%26aufirst%3DAnette%2BGraven%26date%3D2012%26volume%3D22%26issue%3D15%26spage%3D5134%26epage%3D5140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Bubser</span>, <span class="hlFld-ContribAuthor ">Nellie  Byun</span>, <span class="hlFld-ContribAuthor ">Michael R.  Wood</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Muscarinic Receptor Pharmacology and Circuitry for the Modulation of Cognition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 121-166. <a href="https://doi.org/10.1007/978-3-642-23274-9_7" title="DOI URL">https://doi.org/10.1007/978-3-642-23274-9_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-23274-9_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-23274-9_7%26sid%3Dliteratum%253Aachs%26atitle%3DMuscarinic%252BReceptor%252BPharmacology%252Band%252BCircuitry%252Bfor%252Bthe%252BModulation%252Bof%252BCognition%26aulast%3DBubser%26aufirst%3DMichael%26date%3D2012%26date%3D2011%26spage%3D121%26epage%3D166%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DMuscarinic%252BReceptors%26aulast%3DFryer%26aufirst%3DAllison%2BD.%26date%3D2012%26volume%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Decker</span>, <span class="hlFld-ContribAuthor ">Ulrike  Holzgrabe</span>. </span><span class="cited-content_cbyCitation_article-title">M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (7)
                                     , 752. <a href="https://doi.org/10.1039/c2md20025b" title="DOI URL">https://doi.org/10.1039/c2md20025b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20025b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20025b%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DM1%252Bmuscarinic%252Bcetylcholine%252Breceptor%252Ballosteric%252Bmodulators%252Bas%252Bpotential%252Btherapeutic%252Bopportunities%252Bfor%252Btreating%252BAlzheimer%252527s%252Bdisease%26aulast%3DDecker%26aufirst%3DMichael%26date%3D2012%26volume%3D3%26issue%3D7%26spage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjing  Zhan</span>, <span class="hlFld-ContribAuthor ">Jiong  Jia</span>, <span class="hlFld-ContribAuthor ">Bingchuan  Yang</span>, <span class="hlFld-ContribAuthor ">Aiping  Huang</span>, <span class="hlFld-ContribAuthor ">Yanli  Liu</span>, <span class="hlFld-ContribAuthor ">Chen  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">A tandem coupling/smiles rearrangement/cyclization approach to 1,4-benzooxazinones or 1,4-pyridooxazinones under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2012,</strong> <em>2 </em>
                                    (19)
                                     , 7506. <a href="https://doi.org/10.1039/c2ra20334k" title="DOI URL">https://doi.org/10.1039/c2ra20334k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ra20334k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ra20334k%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Btandem%252Bcoupling%25252Fsmiles%252Brearrangement%25252Fcyclization%252Bapproach%252Bto%252B1%25252C4-benzooxazinones%252Bor%252B1%25252C4-pyridooxazinones%252Bunder%252Bmild%252Bconditions%26aulast%3DZhan%26aufirst%3DChunjing%26date%3D2012%26volume%3D2%26issue%3D19%26spage%3D7506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abraham  Fisher</span>. </span><span class="cited-content_cbyCitation_article-title">Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2012,</strong> <em>120 </em>
                                    (s1)
                                     , 22-33. <a href="https://doi.org/10.1111/j.1471-4159.2011.07507.x" title="DOI URL">https://doi.org/10.1111/j.1471-4159.2011.07507.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1471-4159.2011.07507.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1471-4159.2011.07507.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DCholinergic%252Bmodulation%252Bof%252Bamyloid%252Bprecursor%252Bprotein%252Bprocessing%252Bwith%252Bemphasis%252Bon%252BM1%252Bmuscarinic%252Breceptor%25253A%252Bperspectives%252Band%252Bchallenges%252Bin%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DFisher%26aufirst%3DAbraham%26date%3D2012%26date%3D2011%26volume%3D120%26issue%3Ds1%26spage%3D22%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Liguo  Yang</span>, <span class="hlFld-ContribAuthor ">Jingjing  Su</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Lei</span>, <span class="hlFld-ContribAuthor ">Juan  Xiong</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Cao</span>, <span class="hlFld-ContribAuthor ">Yinghe  Hu</span>, <span class="hlFld-ContribAuthor ">Bing  Mei</span>, <span class="hlFld-ContribAuthor ">Jin-Feng  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Attenuation of neurodegenerative phenotypes in Alzheimer-like presenilin 1/presenilin 2 conditional double knockout mice by EUK1001, a promising derivative of xanomeline. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2011,</strong> <em>410 </em>
                                    (2)
                                     , 229-234. <a href="https://doi.org/10.1016/j.bbrc.2011.05.120" title="DOI URL">https://doi.org/10.1016/j.bbrc.2011.05.120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2011.05.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2011.05.120%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DAttenuation%252Bof%252Bneurodegenerative%252Bphenotypes%252Bin%252BAlzheimer-like%252Bpresenilin%252B1%25252Fpresenilin%252B2%252Bconditional%252Bdouble%252Bknockout%252Bmice%252Bby%252BEUK1001%25252C%252Ba%252Bpromising%252Bderivative%252Bof%252Bxanomeline%26aulast%3DWang%26aufirst%3DDong%26date%3D2011%26volume%3D410%26issue%3D2%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of Muscarinic Agonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Parallel Synthesis Protocol to Prepare Analogues of <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBD-methylpolystyrene, 1,2-dichloroethane; (b) Tris-(2-aminoethyl)amine polystyrene resin; (c) TFA; (d) SCX resin; (e) NH<sub>3</sub>/MeOH (4 M); (f) DIPEA, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Intermediates <b>8a</b>−<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaH, Br(CH<sub>2</sub>)<sub>3</sub>X, DMF.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Intermediates <b>7c</b>, <b>7g</b>, and <b>7j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Diethyl malonate, NaH, DMF; (b) AcOH, HCl, reflux; (c) 10% Pd/C, HCOONH<sub>4</sub>, MeOH, reflux; (d) 3-chloropropionyl chloride, DIPEA, ethyl acetate; (e) AlCl<sub>3</sub>, 180 °C; (f) 5% Pd/C, H<sub>2</sub>, EtOH; (g) chloroacetyl chloride, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inverted amide analogue of <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration-dependent stimulation of Ca<sup>2+</sup> mobilization in CHO-hM1 cells by ACh (circles) and <b>17</b> (squares, solid line). Antagonism of response to <b>17</b> by 100 nM atropine (squares, dashed line). Data are the mean of three experiments (±SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Detection of allosteric agonism by Schild regression: Schild regression for the interaction between the orthosteric antagonist atropine and (A) the orthosteric agonist ACh, (B) the orthosteric agonist carbachol, (C) the allosteric agonist <b>2</b>, and (D) compound. Data are from a cell-based Ca<sup>2+</sup> assay. The dashed lines represent a theoretical Schild regression of unit slope as expected for simple competitive antagonism by atropine. In the experiments with acetylcholine and carbachol, the 95% confidence interval of the slope factor included the unit slope, and the −p<i>K</i><sub>b</sub> for atropine was in the range 9.0−9.6 and, hence, in agreement with literature values (<a href="http://www.iuphar-db.org" class="extLink">www.iuphar-db.org</a>). Shown are representative data from three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration-dependent stimulation of Ca<sup>2+</sup> mobilization in CHO-K1 hM1-Y381A cells by acetylcholine (solid circles; EC<sub>50</sub> = 27 000 nM, <i>E</i><sub>max</sub> = 100%), <b>17</b> (solid squares; EC<sub>50</sub> = 97 nM; <i>E</i><sub>max</sub> = 82%), <b>2</b> (solid triangles; EC<sub>50</sub> = 500 nM, <i>E</i><sub>max</sub> = 31%), and <b>3</b> (open triangles, EC<sub>50</sub> = 140 nM; <i>E</i><sub>max</sub> = 72%). Data are the mean of three experiments (±SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Plasma concentration−time plots of <b>17</b> following intravenous (1 mg/kg) and oral (2 mg/kg) administration in Sprague−Dawley rats. Data shown are the mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma (ng/mL) and brain (ng/g) concentration−time courses of <b>17</b> following subcutaneous administration of 20 mg/kg (C57/6J mice) and 10 mg/kg (Sprague−Dawley rats). Each data point represents an average of <i>n</i> = 3 ± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/medium/jm-2010-00697g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>17</b> reverses delay-induced working memory decay in the mouse delayed alternation Y-maze task. The graph shows the percentage of positive alternation of arm entries in successive trial runs following a delay of 1 (“0 sec”) or 60 s. A two-way analysis of variance (ANOVA) with the all pairwise multiple comparison procedure (Student−Newman−Keuls method) revealed an overall difference for factor delay (<i>F</i> = 45.150; <i>p</i> < 0.001) and treatment (<i>F</i> = 5.759; <i>p</i> < 0.001). The vehicle group (black bars) displays a significant decline in correct alternation following the 60 s versus 0 s delay, as well as the low compound <b>17</b> dose groups (white bars) (veh, <i>p</i> < 0.001; 0.31 mg/kg, <i>p</i> < 0.005; 1.3 mg/kg, <i>p</i> < 0.002). Groups treated with 10 and 20 mg/kg <b>17</b> show a dose-dependent, significant increase in correct alternation following the 60 s delay compared to vehicle (10 mg/kg, <i>p</i> < 0.003; 20 mg/kg, <i>p</i> < 0.001). No differences were found between all groups within the 0 s delay (veh vs 0.31 mg/kg, <i>p</i> = 0.152; all others not tested). The dotted line indicates chance performance level (∗, compared to the respective 0 s group; #, compared to the vehicle group at 60 s).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100697g/production/images/large/jm-2010-00697g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100697g&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Caulfield, M. P.</span><span> </span><span class="NLM_article-title">Muscarinic receptors—characterization, coupling, function</span> <span class="citation_source-journal">Pharmacol.Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2F0163-7258%2893%2990027-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=7504306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK2cXlvF0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=319-379&author=M.+P.+Caulfield&title=Muscarinic+receptors%E2%80%94characterization%2C+coupling%2C+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic receptors-characterization, coupling and function</span></div><div class="casAuthors">Caulfield, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-79</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review, with 558 refs., of muscarinic receptor subtype classification, their localization, distribution, coupling mechanisms and functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkGB9pXvA_rVg90H21EOLACvtfcHk0lgsS0xiz9MWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvF0%253D&md5=d57c2e257bd63fb21b719c68cce5826d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2893%2990027-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252893%252990027-B%26sid%3Dliteratum%253Aachs%26aulast%3DCaulfield%26aufirst%3DM.%2BP.%26atitle%3DMuscarinic%2520receptors%25E2%2580%2594characterization%252C%2520coupling%252C%2520function%26jtitle%3DPharmacol.Ther.%26date%3D1993%26volume%3D58%26spage%3D319%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A. J.</span><span> </span><span class="NLM_article-title">Selective loss of central cholinergic neurons in Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1976&pages=1403&author=P.+Daviesauthor=A.+J.+Maloney&title=Selective+loss+of+central+cholinergic+neurons+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520loss%2520of%2520central%2520cholinergic%2520neurons%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1976%26volume%3D2%26spage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Muir, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholine, aging, and Alzheimer’s disease</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=687-696&author=J.+L.+Muir&title=Acetylcholine%2C+aging%2C+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuir%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholine%252C%2520aging%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D56%26spage%3D687%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=423-450&author=J.+Wess&title=Muscarinic+acetylcholine+receptor+knockout+mice%3A+novel+phenotypes+and+clinical+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptor%2520knockout%2520mice%253A%2520novel%2520phenotypes%2520and%2520clinical%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D44%26spage%3D423%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murpht, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahnama, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span> </span><span class="NLM_article-title">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1038%2Fnn992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12483218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Siurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=51-58&author=S.+G.+Anagnostarasauthor=G.+G.+Murphtauthor=S.+E.+Hamiltonauthor=S.+L.+Mitchellauthor=N.+P.+Rahnamaauthor=N.+M.+Nathansonauthor=A.+J.+Silva&title=Selective+cognitive+dysfunction+in+acetylcholine+M1+muscarinic+receptor+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice</span></div><div class="casAuthors">Anagnostaras, Stephan G.; Murphy, Geoffrey G.; Hamilton, Susan E.; Mitchell, Scott L.; Rahnama, Nancy P.; Nathanson, Neil M.; Silva, Alcino J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Blockade of cholinergic neurotransmission by muscarinic receptor antagonists produces profound deficits in attention and memory.  However, the antagonists used in previous studies bind to more than one of the five muscarinic receptor subtypes.  Here the authors examd. memory in mice with a null mutation of the gene coding the M1 receptor, the most densely distributed muscarinic receptor in the hippocampus and forebrain.  In contrast with previous studies using nonselective pharmacol. antagonists, the M1 receptor deletion produced a selective phenotype that included both enhancements and deficits in memory.  Long-term potentiation (LTP) in response to theta burst stimulation in the hippocampus was also reduced in mutant mice.  M1 null mutant mice showed normal or enhanced memory for tasks that involved matching-to-sample problems, but they were severely impaired in non-matching-to-sample working memory as well as consolidation.  The authors' results suggest that the M1 receptor is specifically involved in memory processes for which the cortex and hippocampus interact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgA9iYASunfrVg90H21EOLACvtfcHk0lgsP3uyoTThcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Siurs%253D&md5=9b1c1c058c3c2067d37e94653fdc2363</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnn992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn992%26sid%3Dliteratum%253Aachs%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26aulast%3DMurpht%26aufirst%3DG.%2BG.%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DMitchell%26aufirst%3DS.%2BL.%26aulast%3DRahnama%26aufirst%3DN.%2BP.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26atitle%3DSelective%2520cognitive%2520dysfunction%2520in%2520acetylcholine%2520M1%2520muscarinic%2520receptor%2520mutant%2520mice%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keriakous, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Decreased muscarinic 1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1038%2Fsj.mp.4001199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12476323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1083-1091&author=B.+Deanauthor=M.+McLeodauthor=D.+Keriakousauthor=J.+McKenzieauthor=E.+Scarr&title=Decreased+muscarinic+1+receptors+in+the+dorsolateral+prefrontal+cortex+of+subjects+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia</span></div><div class="casAuthors">Dean, B.; McLeod, M.; Keriakous, D.; McKenzie, J.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1083-1091</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To test the hypothesis that muscarinic receptors are involved in the pathol. of schizophrenia, we measured muscarinic1 (M1R) and muscarinic4(M4R) protein and mRNA as well as [3H]pirenzepine binding in Brodmann's areas (BA) 9 and 40 obtained postmortem from 20 schizophrenic and 20 age/sex-matched control subjects.  There was a significant decrease in [3H]pirenzepine binding to BA 9 (mean ± SEM: 151 ± 15 vs 195 ± 10 fmol mg-1 ETE; P< 0.02), but not BA 40 (143 ± 13 vs 166 ± 11 fmol mg-1 ETE), from subjects with schizophrenia.  The level of M1R protein (0.11 ± 0.007 vs 0.15 ± 0.008 OD; P < 0.01), but not M4R protein, was decreased in BA9 from schizophrenic subjects with neither receptor protein being altered in BA 40.  The level of M1R mRNA was decreased in BA 9 (30 ± 7.0 vs 79 ± 14 dpm × 103 mg-1ETE, P < 0.01) and BA 40 (28 ± 5.9 vs 99 ± 14, P < 0.01) with schizophrenia but M4R mRNA was only decreased in BA 40 (48 ± 6.6 vs 89 ± 9.9, P < 0.005).  These data suggest that the M1R, at least in the dorsolateral prefrontal cortex, may have a role in the pathol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCGS6ZN-tPSbVg90H21EOLACvtfcHk0lgsP3uyoTThcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlyksb4%253D&md5=452f2732469bfcdf46def48079970f80</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001199%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DKeriakous%26aufirst%3DD.%26aulast%3DMcKenzie%26aufirst%3DJ.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DDecreased%2520muscarinic%25201%2520receptors%2520in%2520the%2520dorsolateral%2520prefrontal%2520cortex%2520of%2520subjects%2520with%2520schizophrenia%26jtitle%3DMol.%2520Psychiatry%26date%3D2002%26volume%3D7%26spage%3D1083%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mancama, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrantz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerwin, R.</span><span> </span><span class="NLM_article-title">Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia</span> <span class="citation_source-journal">Am. J. Med. Genet., Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ht1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2003&pages=2-6&author=D.+Mancamaauthor=M.+J.+Arrantzauthor=S.+Landauauthor=R.+Kerwin&title=Reduced+expression+of+the+muscarinic+1+receptor+cortical+subtype+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia</span></div><div class="casAuthors">Mancama D; Arranz M J; Landau S; Kerwin R</div><div class="citationInfo"><span class="NLM_cas:title">American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">119B</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-6</span>
        ISSN:<span class="NLM_cas:issn">1552-4841</span>.
    </div><div class="casAbstract">The involvement of specific pathways mediated through muscarinic receptor activity has been widely implicated in schizophrenia.  Extensive pharmacological evidence supports the systems role in mediating antipsychotic drug efficacy, while mounting physiological evidence demonstrates the presence of significant alterations to normal muscarinic receptor integrity in the disorder.  The mechanisms that facilitate the systems involvement and their magnitude, however, remain poorly understood.  We have proposed that alterations to normal muscarinic receptor expression exist in schizophrenia, and that these significantly influence the physiological changes often reported for the system amongst patients.  In this study, we investigate this potential, and have selected to examine the muscarinic 1 receptor, which constitutes a major target for antipsychotic action and plays a conspicuous role in those regions central to the disorders pathophysiology.  Using relative gene quantification, we measured post-mortem levels of steady-state cortical muscarinic 1 receptor cDNA in patients (N = 20) and unaffected controls (N = 20), and examined group differences in expression levels.  Commensurate with our hypothesis, we observed significant reductions in muscarinic 1 receptor cDNA in our patient sample (F(1,37) = 4.73, P = 0.036) and have estimated this to constitute a 28% decrease compared to the control subjects (95% CI from 2 to 47%).  These results provide evidence in support of altered muscarinic 1 receptor expression in schizophrenia, though further work is needed to corroborate these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0Eb6twwtkvkwlCcfExbvbfW6udTcc2eZ2EvbOAdb6R7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ht1Sksg%253D%253D&md5=0be4e0149cd63cfab47415039059817b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DArrantz%26aufirst%3DM.%2BJ.%26aulast%3DLandau%26aufirst%3DS.%26aulast%3DKerwin%26aufirst%3DR.%26atitle%3DReduced%2520expression%2520of%2520the%2520muscarinic%25201%2520receptor%2520cortical%2520subtype%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520B%26date%3D2003%26volume%3D119%26spage%3D2%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, R.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=R.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0lgtoODYrG9ePg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DR.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">Selective targeting of muscarinic receptors: novel therapeutic appraches for psychotic disorders</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.2174%2F1570159052773413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=63-71&author=C.+Surauthor=G.+G.+Kinney&title=Selective+targeting+of+muscarinic+receptors%3A+novel+therapeutic+appraches+for+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of muscarinic receptors: novel therapeutic approaches for psychotic disorders</span></div><div class="casAuthors">Sur, Cyrille; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a well recognized and debilitating psychiatric disorder composed of several symptoms.  Despite the clin. efficacy of present typical and atypical antipsychotics to alleviate pos. symptoms, neg. symptoms and cognitive disorders are not optimally controlled.  Thus, there is an unmet medical need to develop novel medications with improved tolerability and efficacy for the treatment of these symptoms.  Clin. observations over the past 4 decades have accumulated to support a role of central muscarinic cholinergic neurotransmission in psychosis.  Indeed, recent studies have shown that acetylcholine esterase inhibitors as well as weakly selective muscarinic agonists such as xanomeline improved neuropsychiatric symptoms and cognitive function in Alzheimer's disease patients.  Preclinically, a large body of studies has highlighted the involvement of muscarinic cholinergic signaling in cognition and psychosis.  However the lack of truly selective drugs for the 5 muscarinic receptors has prevented an unambiguous detn. of the role of each receptor subtypes in these behaviors.  Recent progress in behavioral studies of mice deficient for the muscarinic receptors and in the discovery of selective muscarinic agonists have started to unravel the contribution of muscarinic receptor subtypes to complex behaviors.  Accordingly, this review examines the potential of selectively targeting muscarinic receptor subtypes as a therapeutic approach for the treatment of psychotic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW4bfuXG7EVbVg90H21EOLACvtfcHk0lgtoODYrG9ePg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCru7Y%253D&md5=329942d69a2d06e7362e8a2063d0f15d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F1570159052773413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159052773413%26sid%3Dliteratum%253Aachs%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DSelective%2520targeting%2520of%2520muscarinic%2520receptors%253A%2520novel%2520therapeutic%2520appraches%2520for%2520psychotic%2520disorders%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2005%26volume%3D3%26spage%3D63%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sellin, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C.</span><span> </span><span class="NLM_article-title">Muscarinic agonists for the treatment of cognition in schizophrenia</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=985-996&author=A.+K.+Sellinauthor=M.+Shadauthor=C.+Tamminga&title=Muscarinic+agonists+for+the+treatment+of+cognition+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSellin%26aufirst%3DA.%2BK.%26aulast%3DShad%26aufirst%3DM.%26aulast%3DTamminga%26aufirst%3DC.%26atitle%3DMuscarinic%2520agonists%2520for%2520the%2520treatment%2520of%2520cognition%2520in%2520schizophrenia%26jtitle%3DCNS%2520Spectrums%26date%3D2008%26volume%3D13%26spage%3D985%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Fischer, A.</span><span> </span><span class="NLM_article-title">Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=433-442&author=A.+Fischer&title=Cholinergic+treatments+with+emphasis+on+m1+muscarinic+agonists+as+potential+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DCholinergic%2520treatments%2520with%2520emphasis%2520on%2520m1%2520muscarinic%2520agonists%2520as%2520potential%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2008%26volume%3D5%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fischer, A.</span><span> </span><span class="NLM_article-title">Muscarinic receptor agonists in Alzheimer’s disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1999&pages=197-214&author=A.+Fischer&title=Muscarinic+receptor+agonists+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DA.%26atitle%3DMuscarinic%2520receptor%2520agonists%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Drugs%26date%3D1999%26volume%3D12%26spage%3D197%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treppendahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A. J.</span><span> </span><span class="NLM_article-title">Novel functional M1 selective muscarinic agonists. Synthesis and structure−activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2274</span><span class="NLM_x">–</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2274-2283&author=P.+Sauerbergauthor=P.+H.+Olesenauthor=S.+Nielsenauthor=S.+Treppendahlauthor=M.+J.+Sheardownauthor=T.+Honoreauthor=C.+H.+Mitchauthor=J.+S.+Wardauthor=A.+J.+Pike&title=Novel+functional+M1+selective+muscarinic+agonists.+Synthesis+and+structure%E2%88%92activity+relationships+of+3-%281%2C2%2C5-thiadiazolyl%29-1%2C2%2C5%2C6-tetrahydro-1-methylpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a019%26sid%3Dliteratum%253Aachs%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DNielsen%26aufirst%3DS.%26aulast%3DTreppendahl%26aufirst%3DS.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26aulast%3DHonore%26aufirst%3DT.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DPike%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520functional%2520M1%2520selective%2520muscarinic%2520agonists.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25203-%25281%252C2%252C5-thiadiazolyl%2529-1%252C2%252C5%252C6-tetrahydro-1-methylpyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2274%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span> </span><span class="NLM_article-title">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioural symptoms in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1001%2Farchneur.1997.00550160091022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=9109749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=465-473&author=N.+C.+Bodickauthor=W.+W.+Offenauthor=A.+I.+Leveyauthor=N.+R.+Cutlerauthor=S.+G.+Gauthierauthor=A.+Satlinauthor=H.+E.+Shannonauthor=G.+D.+Tollefsonauthor=K.+Rasmussenauthor=F.+P.+Bymasterauthor=D.+J.+Hurleyauthor=W.+Z.+Potterauthor=S.+M.+Paul&title=Effects+of+xanomeline%2C+a+selective+muscarinic+receptor+agonist%2C+on+cognitive+function+and+behavioural+symptoms+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</span></div><div class="casAuthors">Bodick N C; Offen W W; Levey A I; Cutler N R; Gauthier S G; Satlin A; Shannon H E; Tollefson G D; Rasmussen K; Bymaster F P; Hurley D J; Potter W Z; Paul S M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-73</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the therapeutic effects of selective cholinergic replacement with xanomeline tartrate, an m1 and m4 selective muscarinic receptor (mAChR) agonist in patients with probable Alzheimer disease (AD).  DESIGN:  A 6-month, randomized, double-blind, placebo-controlled, parallel-group trial followed by a 1-month, single-blind, placebo washout.  SETTING:  Outpatients at 17 centers in the United States and Canada.  PARTICIPANTS:  A total of 343 men and women at least 60 years of age with mild to moderate AD.  INTERVENTIONS:  Patients received 75, 150, or 225 mg (low, medium, and high doses) of xanomeline per day or placebo for 6 months.  OUTCOME MEASURES:  Scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog), the Clinician's Interview-Based Impression of Change (CIBIC+), the Alzheimer's Disease Symptomatology Scale (ADSS), and the Nurses' Observational Scale for Geriatric Patients (NOSGER).  RESULTS:  A significant treatment effect existed for ADAS-Cog (high dose vs placebo; P < or = .05), and CIBIC+ (high dose vs placebo; P < or = .02).  Treatment Emergent Signs and Symptoms analysis of the ADSS, which assesses behavioral symptoms in patients with AD, disclosed significant (P < or = .002) dose-dependent reductions in vocal outbursts, suspiciousness, delusions, agitation, and hallucinations.  On end-point analysis, NOSGER, which assesses memory, instrumental activities of daily living, self-care, mood, social behavior, and disturbing behavior in the elderly, also showed a significant dose-response relationship (P < or = .02).  In the high-dose arm, 52% of patients discontinued treatment because of adverse events; dose-dependent adverse events were predominantly gastrointestinal in nature.  Syncope, defined as loss of consciousness and muscle tone, occurred in 12.6% of patients in the high-dose group.  CONCLUSIONS:  The observed improvements in ADAS-Cog and CIBIC+ following treatment with xanomeline provide the first evidence, from a large-scale, placebo-controlled clinical trial, that a direct-acting muscarinic receptor agonist can improve cognitive function in patients with AD.  Furthermore, the dramatic and favorable effects on disturbing behaviors in AD suggest a novel approach for treatment of noncognitive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5beLwC0CkxUGy1nwu7K2mfW6udTcc2ebimI6WctHBlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s3mtlyktQ%253D%253D&md5=a1d8d3b2b495133fb37078d387136243</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1997.00550160091022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1997.00550160091022%26sid%3Dliteratum%253Aachs%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DOffen%26aufirst%3DW.%2BW.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DCutler%26aufirst%3DN.%2BR.%26aulast%3DGauthier%26aufirst%3DS.%2BG.%26aulast%3DSatlin%26aufirst%3DA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DTollefson%26aufirst%3DG.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DHurley%26aufirst%3DD.%2BJ.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DEffects%2520of%2520xanomeline%252C%2520a%2520selective%2520muscarinic%2520receptor%2520agonist%252C%2520on%2520cognitive%2520function%2520and%2520behavioural%2520symptoms%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1997%26volume%3D54%26spage%3D465%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buelke-Sam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodick, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzdak, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedberg, M. D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauerberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitch, C. H.</span><span> </span><span class="NLM_article-title">Xanomeline: a selective muscarinic agonist for the treatment of Alzherimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=158-170&author=F.+P.+Bymasterauthor=C.+A.+Whitesittauthor=H.+E.+Shannonauthor=N.+DeLappauthor=J.+S.+Wardauthor=D.+O.+Calligaroauthor=L.+A.+Shipleyauthor=J.+L.+Buelke-Samauthor=N.+C.+Bodickauthor=L.+Fardeauthor=M.+J.+Sheardownauthor=P.+H.+Olesenauthor=K.+T.+Hansenauthor=P.+D.+Suzdakauthor=M.+D.+B.+Swedbergauthor=P.+Sauerbergauthor=C.+H.+Mitch&title=Xanomeline%3A+a+selective+muscarinic+agonist+for+the+treatment+of+Alzherimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DWhitesitt%26aufirst%3DC.%2BA.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DDeLapp%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DShipley%26aufirst%3DL.%2BA.%26aulast%3DBuelke-Sam%26aufirst%3DJ.%2BL.%26aulast%3DBodick%26aufirst%3DN.%2BC.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DHansen%26aufirst%3DK.%2BT.%26aulast%3DSuzdak%26aufirst%3DP.%2BD.%26aulast%3DSwedberg%26aufirst%3DM.%2BD.%2BB.%26aulast%3DSauerberg%26aufirst%3DP.%26aulast%3DMitch%26aufirst%3DC.%2BH.%26atitle%3DXanomeline%253A%2520a%2520selective%2520muscarinic%2520agonist%2520for%2520the%2520treatment%2520of%2520Alzherimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1997%26volume%3D40%26spage%3D158%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Shekar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinckrodt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span> </span><span class="NLM_article-title">Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1176%2Fappi.ajp.2008.06091591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=18593778" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=1033-1039&author=A.+Shekarauthor=W.+Z.+Potterauthor=J.+Lightfootauthor=J.+Lienemannauthor=S.+Dub%C3%A9author=C.+Mallinckrodtauthor=F.+P.+Bymasterauthor=D.+L.+McKinzieauthor=C.+C.+Felder&title=Selective+muscarinic+receptor+agonist+xanomeline+as+a+novel+treatment+approach+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.06091591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.06091591%26sid%3Dliteratum%253Aachs%26aulast%3DShekar%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DLightfoot%26aufirst%3DJ.%26aulast%3DLienemann%26aufirst%3DJ.%26aulast%3DDub%25C3%25A9%26aufirst%3DS.%26aulast%3DMallinckrodt%26aufirst%3DC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26atitle%3DSelective%2520muscarinic%2520receptor%2520agonist%2520xanomeline%2520as%2520a%2520novel%2520treatment%2520approach%2520for%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D1033%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørnholm, B.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of muscarinic agonists: developments since 1990</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1995&pages=37-54&author=E.+K.+Moltzenauthor=B.+Bj%C3%B8rnholm&title=Medicinal+chemistry+of+muscarinic+agonists%3A+developments+since+1990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DBj%25C3%25B8rnholm%26aufirst%3DB.%26atitle%3DMedicinal%2520chemistry%2520of%2520muscarinic%2520agonists%253A%2520developments%2520since%25201990%26jtitle%3DDrugs%2520Future%26date%3D1995%26volume%3D20%26spage%3D37%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Heinrich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paush, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uveges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S. C.</span><span> </span><span class="NLM_article-title">Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M<sub>1</sub>-preferring receptor agonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">605</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1016%2Fj.ejphar.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=19168056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=605&publication_year=2009&pages=53-56&author=J.+N.+Heinrichauthor=J.+A.+Buteraauthor=T.+Carrickauthor=A.+Kramerauthor=D.+Kowalauthor=T.+Lockauthor=K.+L.+Marquisauthor=M.+H.+Paushauthor=M.+Popiolekauthor=S.-C.+Sunauthor=E.+Tsengauthor=A.+J.+Uvegesauthor=S.+C.+Mayer&title=Pharmacological+comparison+of+muscarinic+ligands%3A+historical+versus+more+recent+muscarinic+M1-preferring+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists</span></div><div class="casAuthors">Heinrich, Julia N.; Butera, John A.; Carrick, Tikva; Kramer, Angela; Kowal, Dianne; Lock, Tim; Marquis, Karen L.; Pausch, Mark H.; Popiolek, Mike; Sun, Shaiu-Ching; Tseng, Eugene; Uveges, Albert J.; Mayer, Scott C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">605</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">53-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In functional assay assessments using the five muscarinic receptor subtypes, a second generation of muscarinic M1-preferring receptor agonists [AC-42 (1), AC-260584 (2), 77-LH-28-1 (3) and LY-593039 (4)] was shown to have higher selectivity for muscarinic M1 over M3 receptor as compared to historical agonists [talsaclidine (8), sabcomeline (10), xanomeline (11), WAY-132983 (12), cevimeline (9) and NGX-267 (6)].  Another striking difference of these more recent compds. is their affinities for the dopamine D2 and 5-HT2B receptors.  Taken together, these results suggest that the newer compds. may have a greater clin. safety profile, esp. with regard to muscarinic M3 receptor-mediated events, than the historical agonists, but their affinities for other receptors may still compromise their use to validate the therapeutic potential of muscarinic M1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekmMFFxEgbLVg90H21EOLACvtfcHk0lh8jOIqVSWi-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oms7w%253D&md5=6654ccca50a1db7447e949f5028093dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DCarrick%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DPaush%26aufirst%3DM.%2BH.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DUveges%26aufirst%3DA.%2BJ.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26atitle%3DPharmacological%2520comparison%2520of%2520muscarinic%2520ligands%253A%2520historical%2520versus%2520more%2520recent%2520muscarinic%2520M1-preferring%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D605%26spage%3D53%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skjærbæk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span> </span><span class="NLM_article-title">Discovery of an ectopic activation site on the M<sub>1</sub> muscarinic receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=1297-1302&author=T.+A.+Spaldingauthor=C.+Trotterauthor=N.+Skj%C3%A6rb%C3%A6kauthor=T.+L.+Messierauthor=E.+A.+Currierauthor=E.+S.+Bursteinauthor=D.+Liauthor=U.+Hacksellauthor=M.+R.+Brann&title=Discovery+of+an+ectopic+activation+site+on+the+M1+muscarinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DTrotter%26aufirst%3DC.%26aulast%3DSkj%25C3%25A6rb%25C3%25A6k%26aufirst%3DN.%26aulast%3DMessier%26aufirst%3DT.%2BL.%26aulast%3DCurrier%26aufirst%3DE.%2BA.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520an%2520ectopic%2520activation%2520site%2520on%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D1297%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Spalding, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajpai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span> </span><span class="NLM_article-title">Structural requirements of transmembrane domain 3 for activation by the muscarinic receptor agonists AC-42, AC-260484, clozapine, and <i>N</i>-desmethylclozapine: evidence for three distinct modes of receptor activation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1974-1983&author=T.+A.+Spaldingauthor=J.-N.+Maauthor=T.+R.+Ottauthor=M.+Fribergauthor=A.+Bajpaiauthor=S.+R.+Bradleyauthor=R.+E.+Davisauthor=M.+R.+Brannauthor=E.+S.+Burstein&title=Structural+requirements+of+transmembrane+domain+3+for+activation+by+the+muscarinic+receptor+agonists+AC-42%2C+AC-260484%2C+clozapine%2C+and+N-desmethylclozapine%3A+evidence+for+three+distinct+modes+of+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DT.%2BA.%26aulast%3DMa%26aufirst%3DJ.-N.%26aulast%3DOtt%26aufirst%3DT.%2BR.%26aulast%3DFriberg%26aufirst%3DM.%26aulast%3DBajpai%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26atitle%3DStructural%2520requirements%2520of%2520transmembrane%2520domain%25203%2520for%2520activation%2520by%2520the%2520muscarinic%2520receptor%2520agonists%2520AC-42%252C%2520AC-260484%252C%2520clozapine%252C%2520and%2520N-desmethylclozapine%253A%2520evidence%2520for%2520three%2520distinct%2520modes%2520of%2520receptor%2520activation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1974%26epage%3D1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span> </span><span class="NLM_article-title">Probing the molecular mechanism of interaction between AC-42 and the muscarinic M<sub>1</sub> receptor: direct pharmacological evidence that AC-42 is an allosteric agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=236-246&author=C.+J.+Langmeadauthor=V.+A.+H.+Fryauthor=I.+T.+Forbesauthor=C.+L.+Branchauthor=A.+Christopoulosauthor=M.+D.+Woodauthor=H.+J.+Herdon&title=Probing+the+molecular+mechanism+of+interaction+between+AC-42+and+the+muscarinic+M1+receptor%3A+direct+pharmacological+evidence+that+AC-42+is+an+allosteric+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DFry%26aufirst%3DV.%2BA.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520molecular%2520mechanism%2520of%2520interaction%2520between%2520AC-42%2520and%2520the%2520muscarinic%2520M1%2520receptor%253A%2520direct%2520pharmacological%2520evidence%2520that%2520AC-42%2520is%2520an%2520allosteric%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D69%26spage%3D236%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Blatter, F.; Thygesen, M. B.; Tolf, B.-R.; Berghausen, J.</span><span> </span><span class="NLM_article-title">Method of Synthesis and Isolation of Solid <i>N</i>-Desmethylclozapine and Crystalline Forms Thereof</span>. US 2005282800,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Blatter&author=M.+B.+Thygesen&author=B.-R.+Tolf&author=J.+Berghausen&title=Method+of+Synthesis+and+Isolation+of+Solid+N-Desmethylclozapine+and+Crystalline+Forms+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatter%26aufirst%3DF.%26atitle%3DMethod%2520of%2520Synthesis%2520and%2520Isolation%2520of%2520Solid%2520N-Desmethylclozapine%2520and%2520Crystalline%2520Forms%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwango, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breiniger, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5439-5442&author=T.+M.+Bridgesauthor=A.+E.+Bradyauthor=J.+P.+Kennedyauthor=R.+N.+Danielsauthor=N.+R.+Millerauthor=K.+Kwangoauthor=M.+L.+Breinigerauthor=P.+R.+Gentryauthor=J.+T.+Broganauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Synthesis+and+SAR+of+analogues+of+the+M1+allosteric+agonist+TBPB.+Part+I%3A+Exploration+of+alternative+benzyl+and+privileged+structure+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DMiller%26aufirst%3DN.%2BR.%26aulast%3DKwango%26aufirst%3DK.%26aulast%3DBreiniger%26aufirst%3DM.%2BL.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DBrogan%26aufirst%3DJ.%2BT.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520analogues%2520of%2520the%2520M1%2520allosteric%2520agonist%2520TBPB.%2520Part%2520I%253A%2520Exploration%2520of%2520alternative%2520benzyl%2520and%2520privileged%2520structure%2520moieties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5439%26epage%3D5442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Motulsky, H.; Christopoulos, A.</span> <span class="citation_source-book">Fitting Models to Biological Data Using Linear and Nonlinear Regression</span>; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=H.+Motulsky&author=A.+Christopoulos&title=Fitting+Models+to+Biological+Data+Using+Linear+and+Nonlinear+Regression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMotulsky%26aufirst%3DH.%26btitle%3DFitting%2520Models%2520to%2520Biological%2520Data%2520Using%2520Linear%2520and%2520Nonlinear%2520Regression%26pub%3DOxford%2520University%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rowland, M.; Tozer, T. N.</span> <span class="citation_source-book">Clinical Pharmacokinetics: Concepts and Applications</span>; <span class="NLM_publisher-name">Williams and Wilkins</span>: <span class="NLM_publisher-loc">Baltimore, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=M.+Rowland&author=T.+N.+Tozer&title=Clinical+Pharmacokinetics%3A+Concepts+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DM.%26btitle%3DClinical%2520Pharmacokinetics%253A%2520Concepts%2520and%2520Applications%26pub%3DWilliams%2520and%2520Wilkins%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigner, B.</span><span> </span><span class="NLM_article-title">Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro−in vivo correlations</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.2165%2F00003088-199936030-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=10223169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK1MXivFSrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=211-231&author=T.+Laveauthor=P.+Coassoloauthor=B.+Reigner&title=Prediction+of+hepatic+metabolic+clearance+based+on+interspecies+allometric+scaling+techniques+and+in+vitro%E2%88%92in+vivo+correlations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations</span></div><div class="casAuthors">Lave, Thierry; Coassolo, Philippe; Reigner, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-231</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 63 refs.  This article reviews the methods available for predicting hepatic metabolic clearance in humans, and discusses their application to the processes of drug discovery and development.  The application of these techniques has increased markedly during the past few years because of the improved availability of human liver samples, which has increased the opportunities to use in vitro studies to predict human clearance.  The techniques available involve both empirical and physiol. based approaches.  Allometric scaling using in vitro data from animals and humans combines certain aspects of both approaches.  An evaluation of data retrieved from the literature indicates that, together with in vitro human data, allometric scaling based on a combination of in vitro and in vivo preclin. data can accurately predict clearance in humans.  With this approach, 80% of the predictions were within a 2-fold factor of actual human clearance values, with an overall accuracy of 1.6-fold.  The uncertainties and inaccuracies in predicting human clearance are related to: (i) the specific method that is used to make the prediction; (ii) the exptl. design and the model used to det. the in vitro clearance; (iii) protein binding within the in vitro test system; and (iv) various in vivo factors such as the involvement of extrahepatic metab. and active transport processes, interindividual variability and nonlinearity in pharmacokinetics.  In contrast to purely empirical approaches, the physiol. approach to predicting clearance gives an opportunity to integrate some of these complexities and, therefore, should provide more confidence in the prediction of clearance in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkMK6ClgApibVg90H21EOLACvtfcHk0lhuO3ka_lduHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFSrt74%253D&md5=3764169943504888211b06d3f7e355f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2165%2F00003088-199936030-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199936030-00003%26sid%3Dliteratum%253Aachs%26aulast%3DLave%26aufirst%3DT.%26aulast%3DCoassolo%26aufirst%3DP.%26aulast%3DReigner%26aufirst%3DB.%26atitle%3DPrediction%2520of%2520hepatic%2520metabolic%2520clearance%2520based%2520on%2520interspecies%2520allometric%2520scaling%2520techniques%2520and%2520in%2520vitro%25E2%2588%2592in%2520vivo%2520correlations%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1999%26volume%3D36%26spage%3D211%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mirza, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, R. G.</span><span> </span><span class="NLM_article-title">Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=159-186&author=N.+R.+Mirzaauthor=D.+Petersauthor=R.+G.+Sparks&title=Xanomeline+and+the+antipsychotic+potential+of+muscarinic+receptor+subtype+selective+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DN.%2BR.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DSparks%26aufirst%3DR.%2BG.%26atitle%3DXanomeline%2520and%2520the%2520antipsychotic%2520potential%2520of%2520muscarinic%2520receptor%2520subtype%2520selective%2520agonists%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. C.</span><span> </span><span class="NLM_article-title">TBPB is a highly selective M<sub>1</sub> allosteric muscarinic receptor agonist in vitro and produces robust antipsychotic-like effects in vivo</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">S116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=S116&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=M.+Bubserauthor=A.+Y.+Deutchauthor=L.+C.+Williams&title=TBPB+is+a+highly+selective+M1+allosteric+muscarinic+receptor+agonist+in+vitro+and+produces+robust+antipsychotic-like+effects+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DWilliams%26aufirst%3DL.%2BC.%26atitle%3DTBPB%2520is%2520a%2520highly%2520selective%2520M1%2520allosteric%2520muscarinic%2520receptor%2520agonist%2520in%2520vitro%2520and%2520produces%2520robust%2520antipsychotic-like%2520effects%2520in%2520vivo%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3DS116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=475-481&author=C.+J.+Langmeadauthor=A.+Christopoulos&title=Allosteric+agonists+of+7TM+receptors%3A+expanding+the+pharmacological+toolbox"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520agonists%2520of%25207TM%2520receptors%253A%2520expanding%2520the%2520pharmacological%2520toolbox%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D475%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallorga, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandish, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolnick, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate recetor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">13674</span><span class="NLM_x">–</span> <span class="NLM_lpage">13679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13674-13679&author=C.+Surauthor=P.+J.+Mallorgaauthor=M.+Wittmannauthor=M.+A.+Jacobsonauthor=D.+Pascarellaauthor=J.+B.+Williamsauthor=P.+E.+Brandishauthor=D.+J.+Pettiboneauthor=E.+M.+Scolnickauthor=P.+J.+Conn&title=N-Desmethylclozapine%2C+an+allosteric+agonist+at+muscarinic+1+receptor%2C+potentiates+N-methyl-d-aspartate+recetor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DBrandish%26aufirst%3DP.%2BE.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DScolnick%26aufirst%3DE.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DN-Desmethylclozapine%252C%2520an%2520allosteric%2520agonist%2520at%2520muscarinic%25201%2520receptor%252C%2520potentiates%2520N-methyl-d-aspartate%2520recetor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D13674%26epage%3D13679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Aultman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghaddam, B.</span><span> </span><span class="NLM_article-title">Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2001&pages=353-364&author=J.+M.+Aultmanauthor=B.+Moghaddam&title=Distinct+contributions+of+glutamate+and+dopamine+receptors+to+temporal+aspects+of+rodent+working+memory+using+a+clinically+relevant+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAultman%26aufirst%3DJ.%2BM.%26aulast%3DMoghaddam%26aufirst%3DB.%26atitle%3DDistinct%2520contributions%2520of%2520glutamate%2520and%2520dopamine%2520receptors%2520to%2520temporal%2520aspects%2520of%2520rodent%2520working%2520memory%2520using%2520a%2520clinically%2520relevant%2520task%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D153%26spage%3D353%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Courtney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisog, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungerleider, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haxby, J. V.</span><span> </span><span class="NLM_article-title">An area specialized for spatial working memory in human frontal cortex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1347-1351&author=S.+M.+Courtneyauthor=L.+Petitauthor=J.+M.+Maisogauthor=L.+G.+Ungerleiderauthor=J.+V.+Haxby&title=An+area+specialized+for+spatial+working+memory+in+human+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26aulast%3DPetit%26aufirst%3DL.%26aulast%3DMaisog%26aufirst%3DJ.%2BM.%26aulast%3DUngerleider%26aufirst%3DL.%2BG.%26aulast%3DHaxby%26aufirst%3DJ.%2BV.%26atitle%3DAn%2520area%2520specialized%2520for%2520spatial%2520working%2520memory%2520in%2520human%2520frontal%2520cortex%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kesner, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span> </span><span class="NLM_article-title">Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1093%2Fcercor%2F6.2.311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=8670659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A280%3ADyaK283ovVKhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=311-318&author=R.+P.+Kesnerauthor=M.+E.+Huntauthor=J.+M.+Williamsauthor=J.+M.+Long&title=Prefrontal+cortex+and+working+memory+for+spatial+response%2C+spatial+location%2C+and+visual+object+information+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat</span></div><div class="casAuthors">Kesner R P; Hunt M E; Williams J M; Long J M</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-8</span>
        ISSN:<span class="NLM_cas:issn">1047-3211</span>.
    </div><div class="casAbstract">In the first experiment, rats were trained on a working memory task for a spatial response (right-left turn) information using a delayed matching-to-sample procedure.  Following lesions of the medial prefrontal cortex (MPF), which includes anterior cingulate and medial precentral cortex, there was a profound working memory deficit even at the shortest delay.  In the second experiment, rats were trained on a working memory task for spatial location information using a delayed matching-to-sample procedure.  Following lesions of the MPF, there was only a mild working memory deficit, whereas following dorsal hippocampal lesions there was a profound working memory deficit even at the shortest delay.  In the third experiment, rats were trained on a working memory task for visual object information using a delayed nonmatching-to-sample procedure.  Following lesions of the MPF, there were no working memory deficits, whereas following lesions of the prelimbic and infralimbic cortex there was a profound working memory deficit even at the shortest delay.  The results suggest that different neural subregions of the prefrontal cortex mediate working memory for specific attribute information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTybPSPs4y1npw7prLlxLOzfW6udTcc2eZ7kLw37okRXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283ovVKhsQ%253D%253D&md5=c1b10733743b2ad91adea203e957d1bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2F6.2.311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252F6.2.311%26sid%3Dliteratum%253Aachs%26aulast%3DKesner%26aufirst%3DR.%2BP.%26aulast%3DHunt%26aufirst%3DM.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26atitle%3DPrefrontal%2520cortex%2520and%2520working%2520memory%2520for%2520spatial%2520response%252C%2520spatial%2520location%252C%2520and%2520visual%2520object%2520information%2520in%2520the%2520rat%26jtitle%3DCereb.%2520Cortex%26date%3D1996%26volume%3D6%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Brann, M.; Messier, T.; Currier, E.; Duggento, K.; Friberg, M.; Skjærbæk, N.; Spalding, T.</span><span> </span><span class="NLM_article-title">Compounds with activity on muscarinic receptors</span>, WO200105763,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+Brann&author=T.+Messier&author=E.+Currier&author=K.+Duggento&author=M.+Friberg&author=N.+Skj%C3%A6rb%C3%A6k&author=T.+Spalding&title=Compounds+with+activity+on+muscarinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrann%26aufirst%3DM.%26atitle%3DCompounds%2520with%2520activity%2520on%2520muscarinic%2520receptors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sambrook, J.; Fritsch, E. F.; Maniastis, T.</span> <span class="citation_source-book">Molecular Cloning: A Laboratory Manual</span>; <span class="NLM_publisher-name">Cold Spring Harbor Laboratory Press</span>: <span class="NLM_publisher-loc">Cold Spring Harbor, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=J.+Sambrook&author=E.+F.+Fritsch&author=T.+Maniastis&title=Molecular+Cloning%3A+A+Laboratory+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSambrook%26aufirst%3DJ.%26btitle%3DMolecular%2520Cloning%253A%2520A%2520Laboratory%2520Manual%26pub%3DCold%2520Spring%2520Harbor%2520Laboratory%2520Press%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0liFrJY2v2UuNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm100697g&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm100697g&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm100697g&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0liFrJY2v2UuNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/jm100697g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64333"></div></div></div></div></div><hr /></hr><p class="last">Synthesis procedures, spectroscopic data, and purities for intermediates <b>8b</b>−<b>k</b> and compounds <b>5</b>, <b>6</b>, <b>9</b>−<b>16</b>, and <b>18</b>−<b>38</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100697g/suppl_file/jm100697g_si_001.pdf">jm100697g_si_001.pdf (67.72 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100697g&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-17%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm100697g%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100697g" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bb80cb4223f8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
